<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName A++V2.4.dtd?>
<?SourceDTD.Version 2.4?>
<?ConverterInfo.XSLTName springer2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">BMC Genom Data</journal-id>
    <journal-id journal-id-type="iso-abbrev">BMC Genom Data</journal-id>
    <journal-title-group>
      <journal-title>BMC Genomic Data</journal-title>
    </journal-title-group>
    <issn pub-type="epub">2730-6844</issn>
    <publisher>
      <publisher-name>BioMed Central</publisher-name>
      <publisher-loc>London</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10152008</article-id>
    <article-id pub-id-type="publisher-id">1128</article-id>
    <article-id pub-id-type="doi">10.1186/s12863-023-01128-3</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Database</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>HostSeq: a Canadian whole genome sequencing and clinical data resource</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" equal-contrib="yes">
        <name>
          <surname>Yoo</surname>
          <given-names>S</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author" equal-contrib="yes">
        <name>
          <surname>Garg</surname>
          <given-names>E</given-names>
        </name>
        <xref ref-type="aff" rid="Aff3">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Elliott</surname>
          <given-names>LT</given-names>
        </name>
        <xref ref-type="aff" rid="Aff3">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Hung</surname>
          <given-names>RJ</given-names>
        </name>
        <xref ref-type="aff" rid="Aff4">4</xref>
        <xref ref-type="aff" rid="Aff5">5</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Halevy</surname>
          <given-names>AR</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Brooks</surname>
          <given-names>JD</given-names>
        </name>
        <xref ref-type="aff" rid="Aff4">4</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Bull</surname>
          <given-names>SB</given-names>
        </name>
        <xref ref-type="aff" rid="Aff4">4</xref>
        <xref ref-type="aff" rid="Aff5">5</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Gagnon</surname>
          <given-names>F</given-names>
        </name>
        <xref ref-type="aff" rid="Aff4">4</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Greenwood</surname>
          <given-names>CMT</given-names>
        </name>
        <xref ref-type="aff" rid="Aff6">6</xref>
        <xref ref-type="aff" rid="Aff7">7</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Lawless</surname>
          <given-names>JF</given-names>
        </name>
        <xref ref-type="aff" rid="Aff8">8</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Paterson</surname>
          <given-names>AD</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff4">4</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Sun</surname>
          <given-names>L</given-names>
        </name>
        <xref ref-type="aff" rid="Aff4">4</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zawati</surname>
          <given-names>MH</given-names>
        </name>
        <xref ref-type="aff" rid="Aff6">6</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Lerner-Ellis</surname>
          <given-names>J</given-names>
        </name>
        <xref ref-type="aff" rid="Aff4">4</xref>
        <xref ref-type="aff" rid="Aff9">9</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Abraham</surname>
          <given-names>RJS</given-names>
        </name>
        <xref ref-type="aff" rid="Aff10">10</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Birol</surname>
          <given-names>I</given-names>
        </name>
        <xref ref-type="aff" rid="Aff10">10</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Bourque</surname>
          <given-names>G</given-names>
        </name>
        <xref ref-type="aff" rid="Aff6">6</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Garant</surname>
          <given-names>J-M</given-names>
        </name>
        <xref ref-type="aff" rid="Aff10">10</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Gosselin</surname>
          <given-names>C</given-names>
        </name>
        <xref ref-type="aff" rid="Aff10">10</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Li</surname>
          <given-names>J</given-names>
        </name>
        <xref ref-type="aff" rid="Aff10">10</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Whitney</surname>
          <given-names>J</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Thiruvahindrapuram</surname>
          <given-names>B</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Herbrick</surname>
          <given-names>J-A</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Lorenti</surname>
          <given-names>M</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Reuter</surname>
          <given-names>MS</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Adeoye</surname>
          <given-names>OO</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Liu</surname>
          <given-names>S</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Allen</surname>
          <given-names>U</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff4">4</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Bernier</surname>
          <given-names>FP</given-names>
        </name>
        <xref ref-type="aff" rid="Aff11">11</xref>
        <xref ref-type="aff" rid="Aff12">12</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Biggs</surname>
          <given-names>CM</given-names>
        </name>
        <xref ref-type="aff" rid="Aff13">13</xref>
        <xref ref-type="aff" rid="Aff14">14</xref>
        <xref ref-type="aff" rid="Aff15">15</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Cheung</surname>
          <given-names>AM</given-names>
        </name>
        <xref ref-type="aff" rid="Aff16">16</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Cowan</surname>
          <given-names>J</given-names>
        </name>
        <xref ref-type="aff" rid="Aff2">2</xref>
        <xref ref-type="aff" rid="Aff17">17</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Herridge</surname>
          <given-names>M</given-names>
        </name>
        <xref ref-type="aff" rid="Aff16">16</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Maslove</surname>
          <given-names>DM</given-names>
        </name>
        <xref ref-type="aff" rid="Aff18">18</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Modi</surname>
          <given-names>BP</given-names>
        </name>
        <xref ref-type="aff" rid="Aff14">14</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Mooser</surname>
          <given-names>V</given-names>
        </name>
        <xref ref-type="aff" rid="Aff6">6</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Morris</surname>
          <given-names>SK</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff4">4</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Ostrowski</surname>
          <given-names>M</given-names>
        </name>
        <xref ref-type="aff" rid="Aff4">4</xref>
        <xref ref-type="aff" rid="Aff19">19</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Parekh</surname>
          <given-names>RS</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff4">4</xref>
        <xref ref-type="aff" rid="Aff20">20</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Pfeffer</surname>
          <given-names>G</given-names>
        </name>
        <xref ref-type="aff" rid="Aff11">11</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Suchowersky</surname>
          <given-names>O</given-names>
        </name>
        <xref ref-type="aff" rid="Aff21">21</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Taher</surname>
          <given-names>J</given-names>
        </name>
        <xref ref-type="aff" rid="Aff4">4</xref>
        <xref ref-type="aff" rid="Aff9">9</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Upton</surname>
          <given-names>J</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff4">4</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Warren</surname>
          <given-names>RL</given-names>
        </name>
        <xref ref-type="aff" rid="Aff10">10</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Yeung</surname>
          <given-names>RSM</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff4">4</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Aziz</surname>
          <given-names>N</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Turvey</surname>
          <given-names>SE</given-names>
        </name>
        <xref ref-type="aff" rid="Aff13">13</xref>
        <xref ref-type="aff" rid="Aff14">14</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Knoppers</surname>
          <given-names>BM</given-names>
        </name>
        <xref ref-type="aff" rid="Aff6">6</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Lathrop</surname>
          <given-names>M</given-names>
        </name>
        <xref ref-type="aff" rid="Aff6">6</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Jones</surname>
          <given-names>SJM</given-names>
        </name>
        <xref ref-type="aff" rid="Aff10">10</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Scherer</surname>
          <given-names>SW</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff4">4</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0503-9740</contrib-id>
        <name>
          <surname>Strug</surname>
          <given-names>LJ</given-names>
        </name>
        <address>
          <email>lisa.strug@utoronto.ca</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff4">4</xref>
      </contrib>
      <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.42327.30</institution-id><institution-id institution-id-type="ISNI">0000 0004 0473 9646</institution-id><institution>The Hospital for Sick Children, </institution></institution-wrap>Toronto, ON Canada </aff>
      <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.28046.38</institution-id><institution-id institution-id-type="ISNI">0000 0001 2182 2255</institution-id><institution>University of Ottawa, </institution></institution-wrap>Ottawa, ON Canada </aff>
      <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.61971.38</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7494</institution-id><institution>Simon Fraser University, </institution></institution-wrap>Burnaby, BC Canada </aff>
      <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.17063.33</institution-id><institution-id institution-id-type="ISNI">0000 0001 2157 2938</institution-id><institution>University of Toronto, </institution></institution-wrap>Toronto, ON Canada </aff>
      <aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.250674.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 0626 6184</institution-id><institution>Lunenfeld-Tanenbaum Research Institute, Sinai Health, </institution></institution-wrap>Toronto, ON Canada </aff>
      <aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.14709.3b</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8649</institution-id><institution>McGill University, </institution></institution-wrap>Montreal, QC Canada </aff>
      <aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="GRID">grid.414980.0</institution-id><institution-id institution-id-type="ISNI">0000 0000 9401 2774</institution-id><institution>Lady Davis Institute for Medical Research, Jewish General Hospital, </institution></institution-wrap>Montreal, QC Canada </aff>
      <aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="GRID">grid.46078.3d</institution-id><institution-id institution-id-type="ISNI">0000 0000 8644 1405</institution-id><institution>University of Waterloo, </institution></institution-wrap>Waterloo, ON Canada </aff>
      <aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="GRID">grid.492573.e</institution-id><institution-id institution-id-type="ISNI">0000 0004 6477 6457</institution-id><institution>Sinai Health System, </institution></institution-wrap>Toronto, ON Canada </aff>
      <aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="GRID">grid.434706.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 0410 5424</institution-id><institution>Canada’s Michael Smith Genome Sciences Centre, </institution></institution-wrap>Vancouver, BC Canada </aff>
      <aff id="Aff11"><label>11</label><institution-wrap><institution-id institution-id-type="GRID">grid.22072.35</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7697</institution-id><institution>University of Calgary, </institution></institution-wrap>Calgary, AB Canada </aff>
      <aff id="Aff12"><label>12</label><institution-wrap><institution-id institution-id-type="GRID">grid.413571.5</institution-id><institution-id institution-id-type="ISNI">0000 0001 0684 7358</institution-id><institution>Alberta Children’s Hospital, </institution></institution-wrap>Calgary, AB Canada </aff>
      <aff id="Aff13"><label>13</label><institution-wrap><institution-id institution-id-type="GRID">grid.17091.3e</institution-id><institution-id institution-id-type="ISNI">0000 0001 2288 9830</institution-id><institution>University of British Columbia, </institution></institution-wrap>Vancouver, BC Canada </aff>
      <aff id="Aff14"><label>14</label><institution-wrap><institution-id institution-id-type="GRID">grid.414137.4</institution-id><institution-id institution-id-type="ISNI">0000 0001 0684 7788</institution-id><institution>BC Children’s Hospital, </institution></institution-wrap>Vancouver, BC Canada </aff>
      <aff id="Aff15"><label>15</label><institution-wrap><institution-id institution-id-type="GRID">grid.416553.0</institution-id><institution-id institution-id-type="ISNI">0000 0000 8589 2327</institution-id><institution>St. Paul’s Hospital, </institution></institution-wrap>Vancouver, BC Canada </aff>
      <aff id="Aff16"><label>16</label><institution-wrap><institution-id institution-id-type="GRID">grid.231844.8</institution-id><institution-id institution-id-type="ISNI">0000 0004 0474 0428</institution-id><institution>University Health Network, </institution></institution-wrap>Toronto, ON Canada </aff>
      <aff id="Aff17"><label>17</label><institution-wrap><institution-id institution-id-type="GRID">grid.412687.e</institution-id><institution-id institution-id-type="ISNI">0000 0000 9606 5108</institution-id><institution>The Ottawa Hospital Research Institute, </institution></institution-wrap>Ottawa, ON Canada </aff>
      <aff id="Aff18"><label>18</label><institution-wrap><institution-id institution-id-type="GRID">grid.410356.5</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8331</institution-id><institution>Queen’s University, </institution></institution-wrap>Kingston, ON Canada </aff>
      <aff id="Aff19"><label>19</label><institution-wrap><institution-id institution-id-type="GRID">grid.415502.7</institution-id><institution>St. Michael’s Hospital, Unity Health, </institution></institution-wrap>Toronto, ON Canada </aff>
      <aff id="Aff20"><label>20</label><institution-wrap><institution-id institution-id-type="GRID">grid.417199.3</institution-id><institution-id institution-id-type="ISNI">0000 0004 0474 0188</institution-id><institution>Women’s College Hospital, </institution></institution-wrap>Toronto, ON Canada </aff>
      <aff id="Aff21"><label>21</label><institution-wrap><institution-id institution-id-type="GRID">grid.17089.37</institution-id><institution-id institution-id-type="ISNI">0000 0001 2190 316X</institution-id><institution>University of Alberta, </institution></institution-wrap>Edmonton, AB Canada </aff>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>2</day>
      <month>5</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>2</day>
      <month>5</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2023</year>
    </pub-date>
    <volume>24</volume>
    <elocation-id>26</elocation-id>
    <history>
      <date date-type="received">
        <day>15</day>
        <month>6</month>
        <year>2022</year>
      </date>
      <date date-type="accepted">
        <day>22</day>
        <month>2</month>
        <year>2023</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2023</copyright-statement>
      <license>
        <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p>
      </license>
    </permissions>
    <abstract id="Abs1">
      <p id="Par1">HostSeq was launched in April 2020 as a national initiative to integrate whole genome sequencing data from 10,000 Canadians infected with SARS-CoV-2 with clinical information related to their disease experience. The mandate of HostSeq is to support the Canadian and international research communities in their efforts to understand the risk factors for disease and associated health outcomes and support the development of interventions such as vaccines and therapeutics. HostSeq is a collaboration among 13 independent epidemiological studies of SARS-CoV-2 across five provinces in Canada. Aggregated data collected by HostSeq are made available to the public through two data portals: a phenotype portal showing summaries of major variables and their distributions, and a variant search portal enabling queries in a genomic region. Individual-level data is available to the global research community for health research through a Data Access Agreement and Data Access Compliance Office approval. Here we provide an overview of the collective project design along with summary level information for HostSeq. We highlight several statistical considerations for researchers using the HostSeq platform regarding data aggregation, sampling mechanism, covariate adjustment, and X chromosome analysis. In addition to serving as a rich data source, the diversity of study designs, sample sizes, and research objectives among the participating studies provides unique opportunities for the research community.
</p>
      <sec>
        <title>Supplementary Information</title>
        <p>The online version contains supplementary material available at 10.1186/s12863-023-01128-3.</p>
      </sec>
    </abstract>
    <kwd-group xml:lang="en">
      <title>Keywords</title>
      <kwd>SARS-CoV-2</kwd>
      <kwd>COVID-19</kwd>
      <kwd>Host genetics</kwd>
      <kwd>Clinical databank</kwd>
      <kwd>Whole genome sequencing</kwd>
    </kwd-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100008762</institution-id>
            <institution>Genome Canada</institution>
          </institution-wrap>
        </funding-source>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100011332</institution-id>
            <institution>Innovation, Science and Economic Development Canada</institution>
          </institution-wrap>
        </funding-source>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>PHAC</institution>
        </funding-source>
        <award-id>2021-HQ-000051</award-id>
        <principal-award-recipient>
          <name>
            <surname>Mooser</surname>
            <given-names>V</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>FRQ-S</institution>
        </funding-source>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100013062</institution-id>
            <institution>Génome Québec</institution>
          </institution-wrap>
        </funding-source>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000024</institution-id>
            <institution>Canadian Institutes of Health Research</institution>
          </institution-wrap>
        </funding-source>
        <award-id>GA4-177739</award-id>
        <award-id>MM1-181123</award-id>
        <award-id>447643</award-id>
        <award-id>VR4-172753</award-id>
        <award-id>461170</award-id>
        <award-id>461304</award-id>
        <principal-award-recipient>
          <name>
            <surname>Lerner-Ellis</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Cheung</surname>
            <given-names>AM</given-names>
          </name>
          <name>
            <surname>Yeung</surname>
            <given-names>RSM</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>COVID-19 Immunity Task Force</institution>
        </funding-source>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100021784</institution-id>
            <institution>Ministry of Colleges and Universities</institution>
          </institution-wrap>
        </funding-source>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>Genome Alberta</institution>
        </funding-source>
        <award-id>RRP2</award-id>
        <principal-award-recipient>
          <name>
            <surname>Bernier</surname>
            <given-names>FP</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>Alberta Children’s Hospital</institution>
        </funding-source>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>Mitogen DX</institution>
        </funding-source>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>SickKids Foundation</institution>
        </funding-source>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>University of Toronto</institution>
        </funding-source>
        <award-id>508791</award-id>
        <principal-award-recipient>
          <name>
            <surname>Allen</surname>
            <given-names>U</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000233</institution-id>
            <institution>Genome British Columbia</institution>
          </institution-wrap>
        </funding-source>
        <award-id>COV199</award-id>
        <principal-award-recipient>
          <name>
            <surname>Turvey</surname>
            <given-names>SE</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100010661</institution-id>
            <institution>Southeastern Ontario Academic Medical Organization</institution>
          </institution-wrap>
        </funding-source>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>Providence Healthcare Research Institute </institution>
        </funding-source>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>CFI</institution>
        </funding-source>
        <award-id>HSC0005268/6220200122</award-id>
        <principal-award-recipient>
          <name>
            <surname>Yeung</surname>
            <given-names>RSM</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009003</institution-id>
            <institution>Hotchkiss Brain Institute, University of Calgary</institution>
          </institution-wrap>
        </funding-source>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100012866</institution-id>
            <institution>Cumming School of Medicine, University of Calgary</institution>
          </institution-wrap>
        </funding-source>
      </award-group>
    </funding-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>issue-copyright-statement</meta-name>
        <meta-value>© The Author(s) 2023</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="Sec1">
    <title>Background</title>
    <p id="Par2">Following exposure to SARS-CoV-2 (the virus that causes COVID-19), some individuals remain disease- or symptom-free while others develop a spectrum of symptoms from mild to severe with the potential for fatal outcomes [<xref ref-type="bibr" rid="CR1">1</xref>]. This variability in response to exposure suggests that susceptibility is mediated at least in part by host genetic factors [<xref ref-type="bibr" rid="CR2">2</xref>]. Genetic factors have been associated with acquisition and severity of other viral infections [<xref ref-type="bibr" rid="CR3">3</xref>–<xref ref-type="bibr" rid="CR7">7</xref>], including SARS-CoV-1 [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>]. A growing body of work demonstrates a role for host genetics in SARS-CoV-2 [<xref ref-type="bibr" rid="CR10">10</xref>–<xref ref-type="bibr" rid="CR14">14</xref>]. Despite the relative novelty of the SARS-CoV-2 virus and the challenges of identifying genetic contributors in a changing environment [<xref ref-type="bibr" rid="CR2">2</xref>], several loci contributing to infection susceptibility and illness severity have been identified [<xref ref-type="bibr" rid="CR15">15</xref>]. Associated loci are comprised of rare and common variations and occur throughout the genome, including but not limited to chromosome X and the HLA region on chromosome 6.</p>
    <p id="Par3">In 2020, several countries launched efforts to identify the genetic factors affecting COVID-19 outcomes to support diagnostics, therapy and vaccine development. However, Canada was not poised to do so because, although population-based cohorts exist [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>], a national whole genome sequencing cohort broadly consented for research and translation, and linked to rich clinical and public health data, did not exist at the onset of the global pandemic. Here we describe the development of this national platform to address pressing questions concerning COVID-19 and other health outcomes in Canada. In April 2020, as part of the Canadian pandemic response, Genome Canada (a not-for-profit organization funded by the Government of Canada) launched the Canadian COVID-19 Genomics Network (CanCOGeN; [<xref ref-type="bibr" rid="CR18">18</xref>]). CanCOGeN established a coordinated pan-Canadian network of studies in collaboration with Canada’s national platform for genome sequencing and analysis (CGEn). Beginning June 2020, CGEn developed HostSeq: a national databank of independent clinical and epidemiological studies enrolling SARS-CoV-2-infected participants across Canada. The goal of HostSeq is to create a data repository with whole genome sequencing and harmonized clinical information, including comorbidities for 10,000 Canadians. With the launch of HostSeq, investigators can now begin to address questions of genetic susceptibility to SARS-CoV-2 infection and outcomes from the Canadian perspective. The approvals in place to link HostSeq to other local, provincial or national data resources expand the utility of the resource, including genetic susceptibility for future implications of SARS-CoV-2 infection. Further, summary statistics from association studies of HostSeq have been contributed and are aligned with international efforts including the COVID-19 Host Genetic Initiative (HGI; [<xref ref-type="bibr" rid="CR19">19</xref>]) and COVID Human Genetic Effort (<ext-link ext-link-type="uri" xlink:href="https://www.covidhge.com/">https://www.covidhge.com/</ext-link>). Most importantly, we have established the research project infrastructure necessary for future pan-Canadian genome sequencing studies. In this resource paper introducing the HostSeq Databank, we present its design characteristics, high-level analytic considerations pertaining to it, and the research opportunities this rich resource provides.</p>
  </sec>
  <sec id="Sec2">
    <title>Construction and content</title>
    <sec id="Sec3">
      <title>HostSeq project design</title>
      <p id="Par4">HostSeq (Fig. <xref rid="Fig1" ref-type="fig">1</xref>) is a project representing a consortium of investigator-initiated SARS-CoV-2-related research studies across Canada. Each partner study was required to adhere to core consent elements (Table S<xref rid="MOESM1" ref-type="media">1</xref>), contribute blood (or in rare cases saliva) samples for whole genome sequencing, and provide clinical information using a standardized case report form (Table S<xref rid="MOESM1" ref-type="media">2</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><p>Sample and data flow in HostSeq (Aspects of graphics acquired from Wikimedia Commons)</p></caption><graphic xlink:href="12863_2023_1128_Fig1_HTML" id="MO1"/></fig></p>
      <p id="Par5">Within these studies, eligible participants include individuals of any age with a positive SARS-CoV-2 test performed by any Health Canada approved method. In some studies, suspected cases with clinically assessed COVID-19-related symptoms but without a positive test diagnosis were also included. Within the primary studies, each participant consented to use of their whole genome sequence for future research [<xref ref-type="bibr" rid="CR20">20</xref>]. Participants also consented to the update, linkage and collection of their data from medical records and charts, as well as from administrative databases, and the deposition of data in a cloud-based, access-controlled databank which can be shared with approved researchers including international and commercial researchers. Additionally, participants had the option to consent to be re-contacted for updates or additional health information, or for invitations to participate in new research. Informed consent was obtained from individuals at each of the participating study sites. For the HostSeq Databank, approval was sought from the study’s Research Ethics Board (REB) for inclusion in HostSeq.</p>
      <p id="Par6">The HostSeq Databank shares data with the global research community following review and approval by the HostSeq-independent Data Access Compliance Office (DACO), as described below in the <italic>Availability of Data and Materials</italic> section.</p>
    </sec>
    <sec id="Sec4">
      <title>Whole genome sequencing</title>
      <p id="Par7">All HostSeq samples undergo whole genome sequencing in a standardized fashion at one of the three CGEn nodes: Toronto (The Centre for Applied Genomics at The Hospital for Sick Children), Montréal (McGill Genome Centre at McGill University), and Vancouver (Canada’s Michael Smith Genome Sciences Centre) on the Illumina NovaSeq6000 platform at 30X depth. Prior to sequencing, quality assurance is performed at multiple stages throughout the process [<xref ref-type="bibr" rid="CR21">21</xref>]. Concordance of the genotyping pipeline among sequencing sites is verified using the Ashkenazi trio set from the Genome in a Bottle Consortium [<xref ref-type="bibr" rid="CR22">22</xref>].</p>
      <p id="Par8">Sequenced samples are analyzed jointly using an in-house pipeline encoded in Nextflow [<xref ref-type="bibr" rid="CR23">23</xref>] and Snakemake [<xref ref-type="bibr" rid="CR24">24</xref>], containerized using Docker [<xref ref-type="bibr" rid="CR25">25</xref>]. The Genome Reference Consortium human build 38 (GRCh38 assembly version GCA_000001405.15) reference genome that includes the alternative HLA decoy genes<xref ref-type="fn" rid="Fn1">1</xref> is used. Genomes are processed following the Best Practices guidelines of the Genome Analysis ToolKit (GATK v4.2.5.0). This includes alignment of sequences to the reference genome, and the genotyping of each sample individually followed by joint-calling of all genotypes together. Associated scripts can be found in a public repository (<ext-link ext-link-type="uri" xlink:href="https://svn.bcgsc.ca/bitbucket/users/jmgarant">https://svn.bcgsc.ca/bitbucket/users/jmgarant</ext-link>). Software packages used to process and analyze the WGS data are listed in Table S<xref rid="MOESM1" ref-type="media">3</xref>.</p>
      <p id="Par9">The in-house pipeline is as follows. Sequences are aligned to the reference genome using DRAGEN mapper (DRAGMAP v1.3.0; [<xref ref-type="bibr" rid="CR26">26</xref>]), sorted with Picard tools (v2.25.0) and bases are recalibrated using the Base Quality Score Recalibration (BQSR) of GATK. GATK HaplotypeCaller is used in Dragen mode on diploid samples for short variant discovery. Aligned sequences are thus converted to genomic Variant Calling Format (gVCF) files, which are then filtered and imported to a GATK GenomicsDB for joint-calling using the GATK GenotypeGVCFs tool. We perform HLA Class I typing using OptiType software (v1.3.1; [<xref ref-type="bibr" rid="CR27">27</xref>]); perform housekeeping with bcftools (v1.11) and samtools (v1.14; [<xref ref-type="bibr" rid="CR28">28</xref>]); check for sample contamination using VerifyBamID2 (v2.0.1) [<xref ref-type="bibr" rid="CR29">29</xref>]; check agreement between reported sex-at-birth and sex chromosome composition using PLINK software (v1.90; [<xref ref-type="bibr" rid="CR30">30</xref>]); and predict ancestry admixture [<xref ref-type="bibr" rid="CR31">31</xref>] and relatedness [<xref ref-type="bibr" rid="CR32">32</xref>] using Genetic Relationship and Fingerprinting software (GRAF v2.4). We use PLINK (v2.00; [<xref ref-type="bibr" rid="CR33">33</xref>]) and R (3.6.3; [<xref ref-type="bibr" rid="CR34">34</xref>]) for genetic data analysis. Additionally, we compare the genetic principal components of HostSeq with the 1000 Genomes Project reference populations [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR36">36</xref>] following the guidelines of plinkQC [<xref ref-type="bibr" rid="CR37">37</xref>]. Samples are excluded based on the following checks (Figure S<xref rid="MOESM1" ref-type="media">1</xref>): (i) genotyping call rate &lt; 95%, (ii) sex chromosome composition and reported sex-at-birth mismatch, (iii) samples identified as duplicates, (iv) possibly mislabelled samples, (v) sample contamination rate &gt; 3%, and (vi) mean coverage &lt; 10. The whole genome sequence data are provided in joint VCF format (aligned sequences can also be obtained).</p>
    </sec>
    <sec id="Sec5">
      <title>Contributing studies and data harmonization</title>
      <p id="Par10">As of December 20, 2022, 13 participating studies contributed data and biospecimens to HostSeq (Table S<xref rid="MOESM1" ref-type="media">4</xref>). Although all 13 studies continue collecting clinical information, 6 have completed their participant recruitment. To date, we have harmonized data from all 13 studies. The participating studies are predominantly prospective SARS-CoV-2 studies based in hospitals, and are seeking to identify genetic factors that contribute to varying COVID-19 outcomes. Here we summarize characteristics of the 13 harmonized studies. Three studies—genMARK, Alberta Childhood COVID-19 Cohort (“AB3C”), and Genomic Determinants of COVID-19 (“GD-COVID”) —are using a case–control design, in which laboratory-confirmed COVID-19 cases are matched with controls (see Table S<xref rid="MOESM1" ref-type="media">4</xref> for matching factors and control eligibility). One study—Quebec COVID-19 Biobank (“BQC19”)—collected clinical data and biospecimens from 12 hospitals in Quebec [<xref ref-type="bibr" rid="CR38">38</xref>]. The remaining studies are case-cohorts with patients that either have a confirmed or suspected diagnosis of COVID-19. From these studies, the HostSeq Databank includes data from study subjects on demographics, comorbidities and assessment and treatment provided for COVID-19.</p>
      <p id="Par11">Clinical data from the participating studies is systematically harmonized by the HostSeq team in an ongoing process. In the first stage, we verify the raw data by checking for missingness, consistency, inadmissible values, and aberrant values across the variables. In the second stage, we harmonize the data guided by a set of common definitions and rules, including application of uniform classification, coding, and measurement units specified in the HostSeq Codebook (available through the <italic>HostSeq Phenotype Portal</italic> described below in <italic>HostSeq Data Portals</italic>). For example, all laboratory test variables are converted into predefined units; text entries in French are translated into English; and medications and complications variables are coded by timeline (prior to illness vs. during illness vs. post-discharge follow-up). Any potential data errors detected in the harmonization process are communicated to the participating study teams and resolved through follow-up.</p>
      <p id="Par12">Study-specific sample sizes currently range from 11 to 4,602. To date, in the HostSeq databank the 13 studies have contributed 9,913 clinical records and submitted 10,978 samples (Table <xref rid="Tab1" ref-type="table">1</xref>). With the exception of two studies that have recruitment across multiple provinces (CANCOV, CONCOR-Donor; <italic>n</italic> = 2,196), most studies are province-specific: six studies in Ontario (GENCOV, GenOMICC, SCB, LEFT-GEN, genMARK, Understanding Immunity to Coronaviruses; <italic>n</italic> = 3,114), one in Quebec (BQC19; <italic>n</italic> = 4,602), two in Alberta (AB3C; AB-HGS <italic>n</italic> = 262) and two in British Columbia (GD-COVID, Host Factors; <italic>n</italic> = 804). Table S<xref rid="MOESM1" ref-type="media">4</xref> summarizes their research objectives and study designs. Detailed information for each study is also provided on the CGEn website (<ext-link ext-link-type="uri" xlink:href="https://www.cgen.ca/hostseq-studies-2">https://www.cgen.ca/hostseq-studies-2</ext-link>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Status of DNA sample sequencing (as of December 20, 2022)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">STUDY TITLE</th><th align="left">STUDY<break/>ACRONYM</th><th align="left">SAMPLES</th><th align="left">DATA</th></tr></thead><tbody><tr><td align="left">The Hospital for Sick Children’s COVID-19 Biobank</td><td align="left">SCB</td><td align="left">566</td><td align="left">223</td></tr><tr><td align="left">Genetic Markers of Susceptibility to COVID-19</td><td align="left">genMARK</td><td align="left">876</td><td align="left">738</td></tr><tr><td align="left">The Canadian COVID-19 Prospective Cohort Study</td><td align="left">CANCOV</td><td align="left">1409</td><td align="left">1,284</td></tr><tr><td align="left">The Genetics of Mortality in Critical Care</td><td align="left">GenOMICC</td><td align="left">328</td><td align="left">331</td></tr><tr><td align="left">Implementation of Serological and Molecular Tools to Inform COVID-19 Patient Management</td><td align="left">GENCOV</td><td align="left">1,290</td><td align="left">1,111</td></tr><tr><td align="left">Convalescent Plasma for COVID-19 Research</td><td align="left">CONCOR-Donor</td><td align="left">787</td><td align="left">787</td></tr><tr><td align="left">Host Genetic Factors Underlying Severe COVID-19</td><td align="left">Host Factors</td><td align="left">11</td><td align="left">11</td></tr><tr><td align="left">The Quebec COVID-19 Biobank</td><td align="left">BQC-19</td><td align="left">4,602</td><td align="left">4,323</td></tr><tr><td align="left"><p>Genomic Determinants of COVID-19:</p><p>Integration of Host and Viral Genomic Data to Understand the COVID-19 Epidemiologic Triangle</p></td><td align="left">GD-COVID</td><td align="left">793</td><td align="left">793</td></tr><tr><td align="left">HostSeq—Canadian COVID-19 Human Host Genome Sequencing Ottawa</td><td align="left">LEFT-GEN</td><td align="left">43</td><td align="left">43</td></tr><tr><td align="left">Understanding Immunity to Coronaviruses to Develop New Vaccines and Therapies against 2019-nCoV</td><td align="left"/><td align="left">11</td><td align="left">10</td></tr><tr><td align="left">Alberta Childhood COVID-19 Cohort Study</td><td align="left">AB3C</td><td align="left">188</td><td align="left">188</td></tr><tr><td align="left">Host Genetic Susceptibility to Severe Disease from COVID-19 Infection</td><td align="left">AB-HGS</td><td align="left">74</td><td align="left">71</td></tr><tr><td align="left"><bold>TOTAL</bold></td><td align="left"/><td align="left"><bold>10,978</bold></td><td align="left"><bold>9,913</bold></td></tr></tbody></table><table-wrap-foot><p>SAMPLES column indicates DNA samples submitted to HostSeq for sequencing. DATA column indicates raw clinical records submitted to HostSeq. Of these, a total of 9,427 records have been harmonized</p></table-wrap-foot></table-wrap></p>
    </sec>
  </sec>
  <sec id="Sec6">
    <title>Results</title>
    <sec id="Sec7">
      <title>Clinical data summary</title>
      <p id="Par13">The results discussed in this section are based on approximately 95% of the total expected cohort size of 10,000 participants. Although completeness varies across studies, we have achieved over 70% completeness of key variables capturing demographics, comorbidities, healthcare use, and patient outcome. Among the 9,427 currently available harmonized samples, HostSeq has 54.6% females and 41.5% males (and the remaining 3.9% are missing reported sex-at-birth), with an overall mean age (at recruitment) of 47.9 years. Distributions of sex and age vary across the studies (Table S<xref rid="MOESM1" ref-type="media">5</xref>). Apart from studies including pediatric participants (AB3C, SCB), mean age in the studies ranges from 36.9 years (genMARK) to 63.5 years (GenOMICC). Underlying health conditions are collected in all studies, but using a variety of collection methods (medical chart reviews, participant surveys, and patient interviews). A total of 24 comorbidity variables across cardiovascular, respiratory, immunological, neurological systems, and other pathologies are collected in HostSeq. Distributions of comorbidities across the studies are available through the <italic>HostSeq Phenotype Portal</italic>.</p>
      <p id="Par14">While approximately half of the HostSeq participants were hospitalized and half were assessed in outpatient or community settings, the proportion of hospitalized versus non-hospitalized patients varied substantially across the studies. In all but one study (GenOMICC), participants presented predominantly with mild or moderate symptoms and did not require admission to intensive care units or invasive ventilation support. Of the hospitalized patients, 54.0% were discharged home, 15.0% were transferred to other hospitals or healthcare settings (e.g., rehabilitation centers or long-term care facilities) and 11.9% were reported deceased (Table <xref rid="Tab2" ref-type="table">2</xref>).<table-wrap id="Tab2"><label>Table 2</label><caption><p>Hospitalization and patient outcomes in HostSeq</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="3">HostSeq All Studies (<italic>n</italic> = 9,427)<sup>a</sup>
</th></tr></thead><tbody><tr><td align="left" rowspan="2">Age<sup>b</sup>
</td><td align="left">Mean (SD)</td><td align="left">47.9 (29.1)</td></tr><tr><td align="left">Median (min, Q1, Q3, max)</td><td align="left">48.0 (0.1, 33.4, 61.9, 104.2)</td></tr><tr><td align="left" rowspan="2">Sex at birth<sup>c</sup>
</td><td align="left">Male</td><td align="left">3,911 (41.5%)</td></tr><tr><td align="left">Female</td><td align="left">5,144 (54.6%)</td></tr><tr><td align="left" rowspan="2">Hospitalization<sup>d</sup>
</td><td align="left">Yes</td><td align="left">3,478 (36.9%)</td></tr><tr><td align="left">No</td><td align="left">5,354 (56.8%)</td></tr><tr><td align="left" rowspan="2">ICU admission<sup>e</sup>
</td><td align="left">Yes</td><td align="left">1,148 (12.2%)</td></tr><tr><td align="left">No</td><td align="left">6,558 (69.6%)</td></tr><tr><td align="left" rowspan="5">Patient outcome<sup>f,g</sup>
</td><td align="left">Discharged alive</td><td align="left">1,879 (54.0%)</td></tr><tr><td align="left">Transfer to another facility</td><td align="left">521 (15.0%)</td></tr><tr><td align="left">Palliative discharge</td><td align="left">3 (0.1%)</td></tr><tr><td align="left">Hospitalized</td><td align="left">9 (0.3%)</td></tr><tr><td align="left">Death</td><td align="left">414 (11.9%)</td></tr></tbody></table><table-wrap-foot><p><italic>SD</italic> Standard deviation; <sup>a</sup>
<italic>n</italic> = 9,427 is a subset of the expected cohort of greater than 10,000; <sup>b</sup> Data not available for 605 participants (6.4%); <sup>c</sup> Data not available for 372 participants (3.9%); <sup>d</sup> Data not available for 595 participants (6.3%); <sup>e</sup> Data not available for 1,721 participants (18.3%); <sup>f</sup> Denominator is 3,478 hospitalized participants; <sup>g</sup> Data currently in collection for 652 participants (18.7%)</p></table-wrap-foot></table-wrap></p>
    </sec>
    <sec id="Sec8">
      <title>HostSeq data portals</title>
      <p id="Par15">HostSeq provides public access to two data portals: (1) The <italic>Phenotype Portal</italic> shows summaries for the major variables of the HostSeq harmonized clinical data; and (2) the <italic>Variant Search Portal</italic> enables queries in a genomic region to see all variants and their alleles identified in the HostSeq genomes. Both portals are static platforms that are updated periodically when a new release version of their respective data is available.</p>
      <p id="Par16">The <italic>HostSeq Phenotype Portal</italic> (<ext-link ext-link-type="uri" xlink:href="https://hostseq.ca/phenotypes.html">https://hostseq.ca/phenotypes.html</ext-link>) provides information for clinical variables at aggregate and study-specific levels. Users can access variables by category (e.g., demographics, comorbidities, complications) and view their distributions (categorical variables are presented as boxplots, and numerical variables are presented as histograms and violin plots). Displays are limited to variables with ≥ 70% completeness. Researchers can also find links to the HostSeq study protocol and up-to-date data dictionaries on this portal.</p>
      <p id="Par17">The <italic>HostSeq Variant Search Portal</italic> (<ext-link ext-link-type="uri" xlink:href="https://hostseq.ca/dashboard/variants-search">https://hostseq.ca/dashboard/variants-search</ext-link>) allows for queries of the HostSeq genetic data. The primary querying functionality is supported by the CanDIG-server [<xref ref-type="bibr" rid="CR39">39</xref>], a platform enabling federated querying of genomics data. Beacon APIs [<xref ref-type="bibr" rid="CR40">40</xref>] from the Global Alliance for Genomics and Health (GA4GH) are also built-in to allow HostSeq to join the federated Beacon network. Users can query information about a specific allele of interest. Information about the variants that can be queried includes their position and alleles and the respective internal frequencies of the alleles (minor allele frequencies are reported if they exceed 0.1). All columns in the table can be sorted and filtered.</p>
    </sec>
    <sec id="Sec9">
      <title>Genetic data summary</title>
      <p id="Par18">Results reported in this section are based on an interim joint-called set of 6,500 HostSeq genomes, of which 6,316 passed all quality checks (see <italic>Methods</italic>). Our predicted population structure covers five major ancestry groups (Figs. <xref rid="Fig2" ref-type="fig">2</xref> and S<xref rid="MOESM1" ref-type="media">2</xref>, S<xref rid="MOESM1" ref-type="media">3</xref>; 69% European, 6% Admixed American, 8% East Asian, 8% South Asian, 6% African, and approximately 3% uncategorized) and closely matches self-reported ancestries (where available). Additionally, there are 300 and 518 pairs of first- and second-degree relationships, respectively.<fig id="Fig2"><label>Fig. 2</label><caption><p>PCA projection of HostSeq genomes against reference superpopulations. HostSeq genomes were merged with the 1000 Genomes reference set. The first two principal components of this merged data are shown here with HostSeq genomes in black and 1000 Genomes samples colored by their superpopulation: AFR = African, AMR = Admixed American, EAS = East Asian, SAS = South Asian, EUR = European</p></caption><graphic xlink:href="12863_2023_1128_Fig2_HTML" id="MO2"/></fig></p>
      <p id="Par19">Currently HostSeq provides 174.5 million short variants consisting of single nucleotide variants and indels. We report HLA Class I haplotypes for three loci (<italic>HLA-A</italic>, <italic>HLA-B</italic> and <italic>HLA-C</italic>) with bi-allelic typing at 4-digit resolution (allele group with specific alleles). The numbers of unique alleles for <italic>HLA-A</italic>, <italic>HLA-B</italic> and <italic>HLA-C</italic> in 4436 genomes are 73, 145 and 49, respectively (the most common alleles per locus are <italic>HLA-A*</italic>02:01, <italic>HLA-B*</italic>07:02 and <italic>HLA-C*</italic>07:01).</p>
    </sec>
  </sec>
  <sec id="Sec10">
    <title>Utility and discussion</title>
    <p id="Par20">HostSeq provides unique opportunities to explore the genetics among SARS-CoV-2 positive individuals in Canada and the facilitation of an organizational governance and oversight for researchers in Canada and beyond. Even though the participating studies in HostSeq are heterogenous with different designs and objectives (Table <xref rid="Tab3" ref-type="table">3</xref> and Table S<xref rid="MOESM1" ref-type="media">4</xref>), HostSeq is an opportunity to leverage that diversity to address research questions. Several issues need to be considered when analysing HostSeq data in a given research context. For example: (1) whether data from different studies should be analysed separately or combined (and how to combine those data); (2) the selection strategies used by the contributing studies to recruit participants; (3) adjustment of covariates for association tests with genetic variants; and (4) the details of X chromosome analysis.<table-wrap id="Tab3"><label>Table 3</label><caption><p>Aspects of participant ascertainment in HostSeq</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Desired research study eligibility</th><th align="left">Active infection at recruitment</th><th align="left">Past infection or disease at recruitment</th></tr></thead><tbody><tr><td align="left">Infected participants in ICU</td><td align="left"><p>Host Factors</p><p>BQC19</p><p>CANCOV</p><p>GENCOV</p><p>GenOMICC</p><p>SCB</p></td><td align="left"><p>SCB</p><p>AB-HGS</p></td></tr><tr><td align="left"><p>Infected inpatient participants</p><p>(i.e., hospitalized)</p></td><td align="left"><p>AB3C</p><p>Host Factors</p><p>BQC19</p><p>CANCOV</p><p>GENCOV</p><p>SCB</p></td><td align="left"><p>AB-HGS</p><p>GENCOV</p><p>genMARK</p><p>LEFT-GEN</p><p>SCB</p></td></tr><tr><td align="left">Infected outpatient participants</td><td align="left"><p>AB3C</p><p>BQC19</p><p>CANCOV</p><p>GENCOV</p><p>genMARK</p></td><td align="left"><p>genMARK</p><p>GD-COVID-19</p><p>GENCOV</p><p>LEFT-GEN</p><p>SCB</p></td></tr><tr><td align="left">Infected participants from community enrollment</td><td align="left"/><td align="left">CONCOR-Donor</td></tr></tbody></table><table-wrap-foot><p>Study participants who were not confirmed to be positive for infection either by molecular/serology test or clinical symptoms are not included in this Table</p></table-wrap-foot></table-wrap></p>
    <sec id="Sec11">
      <title>Individual or combined analysis</title>
      <p id="Par21">Whether an investigator’s research question would be best answered by within-study comparisons or analyses including multiple studies will require careful consideration of participant ascertainment criteria. For example, comorbidities might be analyzed within-study then combined via a meta-analysis to account for differences in study designs among the contributing studies. In contrast, for the disease severity indicated by hospitalization duration, it may be appropriate to jointly analyze the subset of studies that focus on in-patient recruitment. Table <xref rid="Tab3" ref-type="table">3</xref> provides details for the recruitment aspects that may frame such research questions. For example, to compare the genetics of hospitalized patients to non-hospitalized patients within the same study, data from AB3C, BQC19, CANCOV, GENCOV, genMARK, LEFT-GEN and SCB could be used. To compare ICU patients to non-ICU hospitalized patients, Host Factors, BQC19, CANCOV, GENCOV and SCB could be used.</p>
      <p id="Par22">Given the heterogeneity of the studies in HostSeq, the best approach for certain outcomes may be to analyse relevant studies individually. The feasibility of combining estimates or test results from separate studies, as in meta-analyses, depends on whether the individual studies measure and estimate the same features. The appropriateness of a joint analysis of participant data from multiple studies in an overarching model (perhaps with inclusion of study effects) also depends on whether the studies measure those same features. Although the combination of study-level estimates or tests can be as efficient as joint analysis in large samples [<xref ref-type="bibr" rid="CR41">41</xref>], meta-analysis of summary data can be less efficient in smaller samples. When individual data are available, joint analysis is recommended, incorporating sparse-data methods for variants with low minor allele counts and outcomes with low prevalence [<xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR43">43</xref>]. Furthermore, with study or environmental factors and other sources of heterogeneity, joint analysis can exploit gene-environment interaction [<xref ref-type="bibr" rid="CR44">44</xref>] and give insight into sources of within- and between-study variation.</p>
      <p id="Par23">Given the dynamic nature of the COVID-19 pandemic, temporal and spatial variation within- and between-studies is another source of heterogeneity that is challenging and deserves consideration. Studies with prolonged recruitment and wide variation in dates of infection may allow such factors to be examined. When looking across the participating HostSeq studies, it may be of interest to examine changes in the profiles of recruited patients as the seropositivity rates and vaccination rates changed with time across Canada and as treatments changed and improved (for example, by combining HostSeq data with serological studies).</p>
    </sec>
    <sec id="Sec12">
      <title>Participant selection mechanism</title>
      <p id="Par24">Most of the participating studies are designed to include individuals who tested positive for SARS-CoV-2 at a participating institution or individuals who volunteered to donate blood and previously had a positive test. For such participants, it can be difficult to specify exactly what population they represent. To reduce bias and improve interpretation of results, the processes by which individuals join a given study needs to be considered [<xref ref-type="bibr" rid="CR45">45</xref>]. Here, we interpret bias relative to the effect of a variable (genetic or otherwise) in a target population. If an analysis is to involve an outcome variable (e.g., hospitalized versus not hospitalized), a genetic variable of interest and some additional covariates, then the validity of standard statistical methods is linked to how the sample inclusion depends on the outcome. Such dependence occurs in response-selective designs in which individuals are included in a study according to the values of an outcome [<xref ref-type="bibr" rid="CR46">46</xref>–<xref ref-type="bibr" rid="CR48">48</xref>]. Except for the simple case–control setting, weighting or conditional estimation is needed to avoid estimation bias of the genetic association. Such methods require estimation or specification of the probability of being selected for inclusion. We encourage analyses that address study sample selection mechanisms.</p>
      <p id="Par25">Methods to account explicitly for selection conditions are similar to methods used for the analysis of secondary traits in case–control studies [<xref ref-type="bibr" rid="CR49">49</xref>, <xref ref-type="bibr" rid="CR50">50</xref>]. From a methodological standpoint, we also encourage studies of bias and Type 1 error control when standard analyses are used (such as unweighted logistic regression). When the selection mechanism is not easily described, comparison of study samples to population or administrative data may provide insights.</p>
      <p id="Par26">Finally, as HostSeq includes various ancestries, care must be taken to avoid confounding through population stratification (for example, by use of stratification, mixed models, and genetic principal components). This issue, alongside issues related to the heterogeneity of participating studies, are not unique to HostSeq, and arise in most collaborative multi-center or consortium-based research.</p>
    </sec>
    <sec id="Sec13">
      <title>Covariate adjustment</title>
      <p id="Par27">The choice of adjustment covariates in tests for association of outcome with a genetic variant is context dependent and open to discussion in many settings [<xref ref-type="bibr" rid="CR51">51</xref>, <xref ref-type="bibr" rid="CR52">52</xref>]. In testing for genetic associations with COVID-19 outcomes, one strategy would be to adjust for factors such as age and sex that may affect selection or the outcome in question but are not associated with the genetic variant (unless it is on the sex chromosomes; as mentioned below in <italic>Sex difference and X Chromosome Analyses</italic> below). We must also consider whether to adjust for factors such as comorbidities, which may be related both to the outcome and to the variant. This is of particular importance for severe COVID-19: in the ICU, 1-year mortality outcomes increase with each additional week spent in ICU, each decade in age, and each additional comorbid illness in the Charlson score [<xref ref-type="bibr" rid="CR53">53</xref>]. From a causal perspective, adjusting for multiple covariates without a clear conceptual framework could lead to adjustment for variables that lie on the causal pathway [<xref ref-type="bibr" rid="CR54">54</xref>]. If there is a causal link from variant to outcome that passes through such a variable, then researchers could choose to test for either direct or indirect effects of the variant. As part of the process of learning about genetic effects on COVID-19 outcomes, we encourage analyses both with and without adjusting for such factors.</p>
      <p id="Par28">For the discovery stage in genetic association studies, power considerations are important. There have been suggestions that adjusting for too many covariates decreases power [<xref ref-type="bibr" rid="CR52">52</xref>, <xref ref-type="bibr" rid="CR55">55</xref>], and that two-phase strategies of genome-wide screening by simple analysis followed by targeted in-depth modelling is adequate and efficient. However, this is an area for which further study is warranted.</p>
    </sec>
    <sec id="Sec14">
      <title>Sex difference and X chromosome analyses</title>
      <p id="Par29">COVID-19 displays sexual dimorphism with greater severity in males [<xref ref-type="bibr" rid="CR56">56</xref>–<xref ref-type="bibr" rid="CR58">58</xref>]. In addition to environmental exposures and sex-specific autosomal genetic effects, it is reasonable to hypothesize that some X chromosomal variants play a role in COVID-19 outcomes. Indeed, one gene on the X-chromosome, the angiotensin-converting enzyme 2 (<italic>ACE2</italic>, Xp22.2), has been reported to be important in SARS-Cov-2 infection and genetic analysis has demonstrated association evidence with <italic>ACE2</italic> variants [<xref ref-type="bibr" rid="CR19">19</xref>].</p>
      <p id="Par30">However, all published GWAS of SARS-CoV-2 susceptibility or COVID-19 severity, to the best of our knowledge, uses the traditional genotype coding (0, 1 and 2 for a female; 0 and 2 for a male) that assumes X-inactivation through a dosage compensation model (i.e., with alleles in the non-pseudo-autosomal regions being expressed exactly half of the time in genetic females [<xref ref-type="bibr" rid="CR59">59</xref>]). Yet, it has been reported that close to one-third of the X chromosome genes can escape X-inactivation [<xref ref-type="bibr" rid="CR60">60</xref>, <xref ref-type="bibr" rid="CR61">61</xref>]; if so, the genotype of a male should be coded 0 and 1 by convention. To robustly deal with X-inactivation uncertainty we recommend the use of recent methods for genetic analysis of SARS-CoV-2 related research questions such as model averaging and selection [<xref ref-type="bibr" rid="CR62">62</xref>, <xref ref-type="bibr" rid="CR63">63</xref>] and an easy-to-implement regression model [<xref ref-type="bibr" rid="CR64">64</xref>]. Rare X-chromosome variant analysis [<xref ref-type="bibr" rid="CR65">65</xref>, <xref ref-type="bibr" rid="CR66">66</xref>] and X-inclusive polygenic risk scores also require careful consideration and further research.</p>
    </sec>
    <sec id="Sec15">
      <title>Health research in the Canadian context</title>
      <p id="Par31">People living in Canada are insured under single-payer health care systems administered at the provincial or territorial level. These systems broadly cover physician and hospital services, as well as procedures. This provides a unique opportunity to conduct passive follow-up to understand the short-term and long-term outcomes related to SARS-CoV-2 infection. Administrative health data are generated through patient contact with the health care systems and maintained in multiple databases that, with the appropriate approvals, can be linked using a unique encoded identifier to study specific, patient-level data (including genetic data). These data are administrative or procedural (e.g., surgeries, emergency department visits, hospital visits, comorbidities, routine medical exams), clinical (e.g., prescription medications, cancer screening), laboratory (e.g., blood measurements), social (e.g., education, income), and environmental (e.g., rurality, walkability, food insecurity, exposure to air pollution). The participant informed consent used by HostSeq allows for linkage to these data, transforming the HostSeq dataset into a longitudinal study. Specifically, linkage to administrative provincial data will provide: 1) a retrospective, longitudinal account of medical histories, health system utilization and diagnoses; and 2) prospective, longitudinal follow-up tracking the natural history of SARS-CoV-2 infection including multisystem inflammatory syndrome in children (MIS-C) and Long COVID, identifying new diagnoses (e.g., diabetes, cancer), long-term health outcomes (e.g., premature mortality), and health resource utilization. Linkage of the HostSeq study samples to provincial administrative data offers opportunities to collect additional data on risk factors and longitudinal outcomes, and opportunities to extend genetic association analyses. Administrative data can also facilitate evaluation of the representativeness of study samples and inform future study design.</p>
      <p id="Par32">The limitations of HostSeq data for investigation of specific scientific questions depend on limitations of the relevant participant studies. In addition, investigations that involve combining data or results from separate participant studies may require assumptions about comparability or heterogeneity; such assumptions should be scrutinized.</p>
    </sec>
  </sec>
  <sec id="Sec16">
    <title>Conclusions</title>
    <p id="Par33">Through the HostSeq initiative, Canada has built research infrastructure to investigate health effects of SARS-CoV-2 infection and COVID-19, and their association with genetic variants. This infrastructure can also be used for future epidemics. The unique features of the HostSeq project highlighted here present novel opportunities to develop, evaluate, and apply statistical methods that contribute to the understanding of genetic associations with COVID-19-related morbidity and mortality, as well as other phenotypes. The augmentation and linkage of the HostSeq questionnaire and genetic databank with other data resources is made possible by broad and flexible consent and will generate a dynamic population-based resource. This will allow for study of a broad range of research questions and sustained productivity over the years to come.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Information</title>
    <sec id="Sec17">
      <p>
        <supplementary-material content-type="local-data" id="MOESM1">
          <media xlink:href="12863_2023_1128_MOESM1_ESM.docx">
            <caption>
              <p><bold>Additional file 1: Table S1.</bold> HostSeq Core Consent Elements. In order to deposit datasets in HostSeq COVID-19 controlled-access Databank, all the elements in this table must be obtained in the research consent. <bold>Table S2.</bold> HostSeq Case Report Form. <bold>Table S3.</bold> Software used for processing WGS data. <bold>Table S4.</bold> List of HostSeq participating studies as described in respective protocols. <bold>Table S5.</bold> Distribution of sex and age across HostSeq studies (<italic>n</italic> = 9,427). SD: Standard deviation; IQR: interquartile range. <bold>Figure S1.</bold> Quality of HostSeq genomes. (A) Missing rate &lt; 5%, (B) Contamination rate &lt; 3%, (C) Mean coverage &gt;10. <bold>Figure S2.</bold> Predicted population admixture and ancestry classification in HostSeq genomes. Each bar represents a genome. Proportion of African, East Asian and European ancestries is determined, and genomes classified into 8 ancestry groups using GRAF-pop. They are further categorized into 5 superpopulations: AFR - African and African-American, AMR - Latin American Asian and Latin American African, EAS - Asian-Pacific Islander and East Asian, SAS - South Asian, and EUR - European. 3% of genomes remain uncategorized. <bold>Figure S3.</bold> Genetic distances score of HostSeq genomes. The four genetic distances (GD1-4) scores from GRAF-pop represent the distance of each genome from several reference populations and are used to predict ancestry. Barycentric coordinates of GD1 and GD2 are used to predict admixture proportion of African, East Asian and European ancestries.</p>
            </caption>
          </media>
        </supplementary-material>
      </p>
    </sec>
  </sec>
</body>
<back>
  <fn-group>
    <fn id="Fn1">
      <label>1</label>
      <p id="Par40">
        <ext-link ext-link-type="uri" xlink:href="https://ftp.1000genomes.ebi.ac.uk/vol1/ftp/technical/reference/GRCh38_reference_genome/">https://ftp.1000genomes.ebi.ac.uk/vol1/ftp/technical/reference/GRCh38_reference_genome/</ext-link>
      </p>
    </fn>
    <fn>
      <p>
        <bold>Publisher’s Note</bold>
      </p>
      <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
    </fn>
    <fn>
      <p>S Yoo and E Garg contributed equally.</p>
    </fn>
  </fn-group>
  <ack>
    <title>Acknowledgements</title>
    <p>We wish to express gratitude to all HostSeq project participant studies and the individual participants within these studies for their contribution.</p>
  </ack>
  <notes notes-type="author-contribution">
    <title>Authors’ contributions</title>
    <p>LJS led the study design and implementation. Data harmonization: SY; genomic data analysis: EG. Genetic epidemiology: LJS, JDB, SBB, LTE, FG, CMTG, RJH, JFL, ADP, LS. Writing: SY, EG, LTE, RJH, ARH, JDB, SBB, FG, CMTG, JFL, ADP, LS, LJS. Data processing and sharing: SY, EG, LTE, MLo, ARH, RJSA, IB, GB, J-MG, CG, JL, JW, BT, MSR, J-AH, OOA, SL, MHZ; SJMJ led the data processing and sharing. Study contributors: JL-E, UA, FPB, CMB, AMC, JC, MH, DMM, BPM, VM, SKM, MO, RSP, GP, OS, JT, SET, JU, RLW, RSMY. NA coordinated the three CGEn nodes; SET led study site recruitment; BMK designed the consent and data access process; MLa led the Quebec site; SJ led sequence informatics and the variant portal; NA, SWS and LJS provided overall study oversight. The author(s) read and approved the final manuscript.
</p>
  </notes>
  <notes notes-type="funding-information">
    <title>Funding</title>
    <p>
      <table-wrap id="Taba">
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th align="left">PI, Affiliations</th>
              <th align="left">Study name</th>
              <th align="left">Grants (funder and details)</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left">Stephen Scherer, Lisa Strug, The Hospital for Sick Children, Toronto, ON</td>
              <td align="left">
                <bold>CGEn HostSeq—Canadian COVID-19 Human Host Genome Sequencing Databank</bold>
              </td>
              <td align="left">Genome Canada, Innovation, Science and Economic Development Canada</td>
            </tr>
            <tr>
              <td align="left">Vincent Mooser, CGEn-Montreal, QC</td>
              <td align="left">
                <bold>Biobanque Quebec COVID-19</bold>
              </td>
              <td align="left">
                <p>PHAC 2021-HQ-000051</p>
                <p>FRQ-S</p>
                <p>MSSS</p>
              </td>
            </tr>
            <tr>
              <td align="left">Rae Yeung, The Hospital for Sick Children, Toronto, ON</td>
              <td align="left">
                <bold>SickKids COVID-19 Biobank</bold>
              </td>
              <td align="left">
                <p>CFI cost center # 6,220,200,122 (Proposal ID HSC0005268)</p>
                <p>CIHR/COVID-19 Immunity Task Force:</p>
                <p>CIHR GA4-177,739</p>
                <p>CIHR MM1-181,123</p>
              </td>
            </tr>
            <tr>
              <td align="left">Angela Cheung and Margaret Herridge, University Health Network, Toronto, ON</td>
              <td align="left">
                <bold>The Canadian COVID-19 Prospective Cohort Study (CanCOV)</bold>
              </td>
              <td align="left">
                <p>Canadian Institutes of Health Research (CIHR), COVID-19 Rapid Research Funding Opportunity—Clinical Management and Health System</p>
                <p>CIHR/COVID-19 Immunity Task Force:</p>
                <p>Grant number: 447643</p>
              </td>
            </tr>
            <tr>
              <td align="left">Jordan Lerner-Ellis, Jennifer Taher, Sinai Health, Toronto, ON</td>
              <td align="left">
                <bold>Implementation of serological and molecular tools to inform COVID-19 patient management (GENCOV)</bold>
              </td>
              <td align="left">
                <p>CIHR #VR4-172,753</p>
                <p>CIHR sub-awards: # 461,170 and #461,304</p>
              </td>
            </tr>
            <tr>
              <td align="left">Rulan Parekh, The Hospital for Sick Children, Toronto, ON</td>
              <td align="left">
                <bold>Adaptive Immunity and Outcomes of Convalescent Plasma</bold>
              </td>
              <td align="left">Ministry of Colleges and Universities (Ontario COVID-19 Rapid Research Fund)</td>
            </tr>
            <tr>
              <td align="left">Francois Bernier, University of Calgary, Calgary, AB</td>
              <td align="left">
                <bold>Alberta Childhood COVID-19 Cohort (ABCCC)</bold>
              </td>
              <td align="left">
                <p>Genome Alberta (RRP2)</p>
                <p>Alberta Children’s Hospital</p>
                <p>Mitogen DX</p>
              </td>
            </tr>
            <tr>
              <td align="left">Upton Allen, The Hospital for Sick Children, Toronto, ON</td>
              <td align="left">
                <bold>COVID-19 genMARK study</bold>
              </td>
              <td align="left">
                <p>SickKids Foundation</p>
                <p>University of Toronto # 508,791</p>
              </td>
            </tr>
            <tr>
              <td align="left">Stuart Turvey, BC Children’s Hospital, Vancouver, BC</td>
              <td align="left">
                <bold>Genomic determinants of COVID-19</bold>
              </td>
              <td align="left">Genome British Columbia COV199</td>
            </tr>
            <tr>
              <td align="left">David Maslove, Queens University, Kingston, ON</td>
              <td align="left">
                <bold>Genetics of Mortality in critical care (GenOMICC)</bold>
              </td>
              <td align="left">Ontario Innovation Fund Innovation Grant administered by the Southeastern Ontario Academic Medical Organization (SEAMO)</td>
            </tr>
            <tr>
              <td align="left">Catherine Biggs, Stuart Turvey, BC Children’s Hospital, Vancouver, BC</td>
              <td align="left">
                <bold>Improving outcomes through precision medicine for adults with primary immunodeficiencies</bold>
              </td>
              <td align="left">Providence Healthcare Research Institute</td>
            </tr>
            <tr>
              <td align="left">Mario Ostrowski, St. Michael’s Hospital, Unity Health, Toronto, ON</td>
              <td align="left">
                <bold>Understanding Immunity to Coronaviruses to Develop New Vaccines and Therapies against 2019-nCoV</bold>
              </td>
              <td align="left">CIHR VR1-172,711</td>
            </tr>
            <tr>
              <td align="left">Gerald Pfeffer, University of Calgary, Calgary, AB</td>
              <td align="left">
                <bold>Host Genetic Susceptibility to Severe Disease from COVID-19 Infection</bold>
              </td>
              <td align="left">
                <p>Hotchkiss Brain Institute, University of Calgary</p>
                <p>Cumming School of Medicine, University of Calgary</p>
              </td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
    </p>
  </notes>
  <notes notes-type="data-availability">
    <title>Availability of data and materials</title>
    <p>The datasets generated and analysed during the current study are made available to researchers worldwide through a Data Access Agreement and Data Access Compliance Office (DACO) approval (<ext-link ext-link-type="uri" xlink:href="https://www.cgen.ca/daco-main">https://www.cgen.ca/daco-main</ext-link>). The datasets are deposited in the HostSeq Databank, which is a data repository that facilitates data access controls that are suitable for hosting sensitive health data. Access to this repository is granted to any researcher with DACO approval. The DACO verifies that the proposed research has REB approval from their host institution and conforms to HostSeq’s REB-approved SARS-CoV-2 or other health outcome research. DACO-approved researchers sign inter-institutional legal agreements, which outline how the shared data is to be used, stored, and privacy protected.</p>
    <p>Aggregated data are publicly available through two data portals: a phenotype portal showing summaries of major variables (<ext-link ext-link-type="uri" xlink:href="https://hostseq.ca/phenotypes.html">https://hostseq.ca/phenotypes.html</ext-link>) and their distributions, and a variant search portal enabling queries in a genomic region (<ext-link ext-link-type="uri" xlink:href="https://hostseq.ca/dashboard/variants-search">https://hostseq.ca/dashboard/variants-search</ext-link>). Access to the variant search portal requires a login (any researcher can register for a login to the variant search portal).</p>
    <p>The code used for processing the WGS data can be found in a publicly accessible repository: <ext-link ext-link-type="uri" xlink:href="https://svn.bcgsc.ca/bitbucket/users/jmgarant">https://svn.bcgsc.ca/bitbucket/users/jmgarant</ext-link>.</p>
  </notes>
  <notes>
    <title>Declarations</title>
    <notes id="FPar1">
      <title>Ethics approval and consent to participate</title>
      <p id="Par34">HostSeq was approved by the Research Ethics Board of the Hospital for Sick Children (lead site) (#1000070720 from 2020-present). Written informed consent was obtained from all participants or parents/guardians/substitute decision makers prior to inclusion in the study.</p>
      <p id="Par35">Additional REB information from the participating PIs:</p>
      <p id="Par36">
        <table-wrap id="Tabb">
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th align="left">Site</th>
                <th align="left">PI</th>
                <th align="left">REB</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left">The Hospital for Sick Children</td>
                <td align="left">Stephen Scherer</td>
                <td align="left">1000070720</td>
              </tr>
              <tr>
                <td align="left">The Hospital for Sick Children</td>
                <td align="left">Rae Yeung</td>
                <td align="left">1000070060</td>
              </tr>
              <tr>
                <td align="left">The Hospital for Sick Children</td>
                <td align="left">Upton Allen</td>
                <td align="left">1000069580</td>
              </tr>
              <tr>
                <td align="left">University Health Network</td>
                <td align="left">Angela Cheung</td>
                <td align="left">CTO ID 2157</td>
              </tr>
              <tr>
                <td align="left">Queens University</td>
                <td align="left">David Maslove</td>
                <td align="left">CTO ID 3209</td>
              </tr>
              <tr>
                <td align="left">Mount Sinai Hospital</td>
                <td align="left">Jordan Lerner-Ellis</td>
                <td align="left">CTO ID 3302</td>
              </tr>
              <tr>
                <td align="left">The Hospital for Sick Children</td>
                <td align="left">Rulan Parekh</td>
                <td align="left">1000070462</td>
              </tr>
              <tr>
                <td align="left">BC Children's Hospital</td>
                <td align="left">Catherine Biggs</td>
                <td align="left">H20-01667</td>
              </tr>
              <tr>
                <td align="left">University of Montreal Health Centre</td>
                <td align="left"/>
                <td align="left">19.389 (internal) MP-02–2020-8929 (multicentre)</td>
              </tr>
              <tr>
                <td align="left">BC Children;s Hospital</td>
                <td align="left">Stuart Turvey</td>
                <td align="left">H21-00054</td>
              </tr>
              <tr>
                <td align="left">The Ottawa Hospital</td>
                <td align="left">Juthaporn Cowan</td>
                <td align="left">20210119-01H</td>
              </tr>
              <tr>
                <td align="left">Unity Health</td>
                <td align="left">Mario Ostrowski</td>
                <td align="left">20–044</td>
              </tr>
              <tr>
                <td align="left">University of Calgary</td>
                <td align="left">Gerald Pfeffer</td>
                <td align="left">20-0574_MOD3</td>
              </tr>
              <tr>
                <td align="left">University of Calgary</td>
                <td align="left">Francois Bernier</td>
                <td align="left">20-0480_MOD6</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
      </p>
    </notes>
    <notes id="FPar2">
      <title>Consent for publication</title>
      <p id="Par37">Not applicable.</p>
    </notes>
    <notes id="FPar3" notes-type="COI-statement">
      <title>Competing interests</title>
      <p id="Par38">The authors declare that they have no competing interests.</p>
    </notes>
  </notes>
  <ref-list id="Bib1">
    <title>References
</title>
    <ref id="CR1">
      <label>1.</label>
      <mixed-citation publication-type="other">Government of Canada. COVID-19 signs, symptoms and severity of disease: A clinician guide. 2021 [Accessed Summer 2022]. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection/guidance-documents/signs-symptoms-severity.html">https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection/guidance-documents/signs-symptoms-severity.html</ext-link>.
</mixed-citation>
    </ref>
    <ref id="CR2">
      <label>2.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lin</surname>
            <given-names>YC</given-names>
          </name>
          <name>
            <surname>Brooks</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Bull</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Gagnon</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Greenwood</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Hung</surname>
            <given-names>R</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Statistical power in COVID-19 case-control host genomic study design</article-title>
        <source>Genome Med</source>
        <year>2020</year>
        <volume>12</volume>
        <issue>1</issue>
        <fpage>115</fpage>
        <?supplied-pmid 33371892?>
        <pub-id pub-id-type="pmid">33371892</pub-id>
      </element-citation>
    </ref>
    <ref id="CR3">
      <label>3.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Allers</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Schneider</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>CCR5Δ32 mutation and HIV infection: Basis for curative HIV therapy</article-title>
        <source>Curr Opin Virol</source>
        <year>2015</year>
        <volume>14</volume>
        <fpage>24</fpage>
        <lpage>29</lpage>
        <?supplied-pmid 26143158?>
        <pub-id pub-id-type="pmid">26143158</pub-id>
      </element-citation>
    </ref>
    <ref id="CR4">
      <label>4.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Nordgren</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Svensson</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>Genetic susceptibility to human norovirus infection: An Update</article-title>
        <source>Viruses</source>
        <year>2019</year>
        <volume>11</volume>
        <issue>3</issue>
        <fpage>226</fpage>
        <?supplied-pmid 30845670?>
        <pub-id pub-id-type="pmid">30845670</pub-id>
      </element-citation>
    </ref>
    <ref id="CR5">
      <label>5.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Coppola</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Marrone</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Pisaturo</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Starace</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Signoriello</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Gentile</surname>
            <given-names>I</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection</article-title>
        <source>Eur J Clin Microbiol Infect Dis</source>
        <year>2014</year>
        <volume>33</volume>
        <issue>4</issue>
        <fpage>559</fpage>
        <lpage>567</lpage>
        <?supplied-pmid 24081499?>
        <pub-id pub-id-type="pmid">24081499</pub-id>
      </element-citation>
    </ref>
    <ref id="CR6">
      <label>6.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Trandem</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Anghelina</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Perlman</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Regulatory T cells in hibit T cell proliferation and decrease demyelination in mice chronically infected with a coronavirus</article-title>
        <source>J Immunol</source>
        <year>2010</year>
        <volume>184</volume>
        <issue>8</issue>
        <fpage>4391</fpage>
        <lpage>4400</lpage>
        <?supplied-pmid 20208000?>
        <pub-id pub-id-type="pmid">20208000</pub-id>
      </element-citation>
    </ref>
    <ref id="CR7">
      <label>7.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mahallawi</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Khabour</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Makhdoum</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Suliman</surname>
            <given-names>B</given-names>
          </name>
        </person-group>
        <article-title>MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile</article-title>
        <source>Cytokine</source>
        <year>2018</year>
        <volume>104</volume>
        <fpage>8</fpage>
        <lpage>13</lpage>
        <?supplied-pmid 29414327?>
        <pub-id pub-id-type="pmid">29414327</pub-id>
      </element-citation>
    </ref>
    <ref id="CR8">
      <label>8.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ng</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Lau</surname>
            <given-names>KM</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Cheng</surname>
            <given-names>SH</given-names>
          </name>
          <name>
            <surname>Chan</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Hui</surname>
            <given-names>P</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Association of human-leukocyte-antigen class I (B*0703) and class II (DRB1*0301) genotypes with susceptibility and resistance to the development of severe acute respiratory syndrome</article-title>
        <source>J Infect Dis</source>
        <year>2004</year>
        <volume>190</volume>
        <issue>3</issue>
        <fpage>515</fpage>
        <lpage>518</lpage>
        <?supplied-pmid 15243926?>
        <pub-id pub-id-type="pmid">15243926</pub-id>
      </element-citation>
    </ref>
    <ref id="CR9">
      <label>9.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lin</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Tseng</surname>
            <given-names>HK</given-names>
          </name>
          <name>
            <surname>Trejaut</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>HL</given-names>
          </name>
          <name>
            <surname>Loo</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Chu</surname>
            <given-names>CC</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Association of HLA class I with severe acute respiratory syndrome coronavirus infection</article-title>
        <source>BMC Med Genet</source>
        <year>2003</year>
        <volume>4</volume>
        <issue>1</issue>
        <fpage>1</fpage>
        <lpage>7</lpage>
        <pub-id pub-id-type="pmid">12529183</pub-id>
      </element-citation>
    </ref>
    <ref id="CR10">
      <label>10.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pairo-Castineira</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Clohisey</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Klaric</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Bretherick</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Rawlik</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Pasko</surname>
            <given-names>D</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Genetic mechanisms of critical illness in COVID-19</article-title>
        <source>Nature</source>
        <year>2021</year>
        <volume>591</volume>
        <issue>7848</issue>
        <fpage>92</fpage>
        <lpage>98</lpage>
        <?supplied-pmid 33307546?>
        <pub-id pub-id-type="pmid">33307546</pub-id>
      </element-citation>
    </ref>
    <ref id="CR11">
      <label>11.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kousathanas</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Pairo-Castineira</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Rawlik</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Stuckey</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Odhams</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Walker</surname>
            <given-names>S</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Whole genome sequencing reveals host factors underlying critical COVID-19</article-title>
        <source>Nature</source>
        <year>2022</year>
        <volume>607</volume>
        <issue>7917</issue>
        <fpage>97</fpage>
        <lpage>103</lpage>
        <?supplied-pmid 35255492?>
        <pub-id pub-id-type="pmid">35255492</pub-id>
      </element-citation>
    </ref>
    <ref id="CR12">
      <label>12.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <collab>COVID-19 Host Genetics Initiative</collab>
        </person-group>
        <article-title>Mapping the human genetic architecture of COVID-19</article-title>
        <source>Nature</source>
        <year>2021</year>
        <volume>600</volume>
        <issue>7889</issue>
        <fpage>472</fpage>
        <lpage>7</lpage>
        <pub-id pub-id-type="pmid">34237774</pub-id>
      </element-citation>
    </ref>
    <ref id="CR13">
      <label>13.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Bastard</surname>
            <given-names>P</given-names>
          </name>
          <collab>COVID Human Genetic Effort</collab>
          <name>
            <surname>Cobat</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Casanova</surname>
            <given-names>JL</given-names>
          </name>
        </person-group>
        <article-title>Human genetic and immunological determinants of critical COVID-19 pneumonia</article-title>
        <source>Nature</source>
        <year>2022</year>
        <volume>603</volume>
        <issue>7902</issue>
        <fpage>587</fpage>
        <lpage>98</lpage>
        <?supplied-pmid 35090163?>
        <pub-id pub-id-type="pmid">35090163</pub-id>
      </element-citation>
    </ref>
    <ref id="CR14">
      <label>14.</label>
      <mixed-citation publication-type="other">COVID-19 Host Genetics Initiative. A first update on mapping the human genetic architecture of COVID-19. Nature. 2022;608(7921):E1-E10.</mixed-citation>
    </ref>
    <ref id="CR15">
      <label>15.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Niemi</surname>
            <given-names>MEK</given-names>
          </name>
          <name>
            <surname>Daly</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>Ganna</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>The human genetic epidemiology of COVID-19</article-title>
        <source>Nat Rev Genet</source>
        <year>2022</year>
        <volume>23</volume>
        <issue>5</issue>
        <fpage>533</fpage>
        <lpage>546</lpage>
        <?supplied-pmid 35501396?>
        <pub-id pub-id-type="pmid">35501396</pub-id>
      </element-citation>
    </ref>
    <ref id="CR16">
      <label>16.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Raina</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Wolfson</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Kirkland</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Griffith</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Oremus</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Patterson</surname>
            <given-names>C</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The Canadian Longitudinal Study on Aging (CLSA)</article-title>
        <source>Can J Aging Rev Can Vieil</source>
        <year>2009</year>
        <volume>28</volume>
        <issue>3</issue>
        <fpage>221</fpage>
        <lpage>229</lpage>
      </element-citation>
    </ref>
    <ref id="CR17">
      <label>17.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Dummer</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Awadalla</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Boileau</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Craig</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Fortier</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Goel</surname>
            <given-names>V</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The Canadian partnership for tomorrow project: a pan-Canadian platform for research on chronic disease prevention</article-title>
        <source>Can Med Assoc J</source>
        <year>2018</year>
        <volume>190</volume>
        <issue>23</issue>
        <fpage>E710</fpage>
        <lpage>E717</lpage>
        <pub-id pub-id-type="pmid">29891475</pub-id>
      </element-citation>
    </ref>
    <ref id="CR18">
      <label>18.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Song</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Brinkman</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Gill</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Griffiths</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Hsiao</surname>
            <given-names>W</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Addressing privacy concerns in sharing viral sequences and minimum contextual data in a public repository during the COVID-19 pandemic</article-title>
        <source>Front Genet</source>
        <year>2022</year>
        <volume>12</volume>
        <fpage>716541</fpage>
        <?supplied-pmid 35401651?>
        <pub-id pub-id-type="pmid">35401651</pub-id>
      </element-citation>
    </ref>
    <ref id="CR19">
      <label>19.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <collab>COVID-19 Host Genetics Initiative</collab>
        </person-group>
        <article-title>A first update on mapping the human genetic architecture of COVID-19</article-title>
        <source>Nature</source>
        <year>2022</year>
        <volume>608</volume>
        <issue>7921</issue>
        <fpage>97</fpage>
        <lpage>103</lpage>
      </element-citation>
    </ref>
    <ref id="CR20">
      <label>20.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Knoppers</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Beauvais</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Joly</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Zawati</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Rousseau</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Chasse</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Modeling consent in the time of COVID-19</article-title>
        <source>J Law Biosci</source>
        <year>2020</year>
        <volume>7</volume>
        <issue>1</issue>
        <fpage>1</fpage>
        <lpage>6</lpage>
      </element-citation>
    </ref>
    <ref id="CR21">
      <label>21.</label>
      <mixed-citation publication-type="other">Corbett R, Eveleigh R, Whitney J, Barai N, Bourgey M, Chuah E, et al. A distributed whole genome sequencing benchmark study. Front Genet. 2020;11:612515.</mixed-citation>
    </ref>
    <ref id="CR22">
      <label>22.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zook</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Catoe</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>McDaniel</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Extensive sequencing of seven human genomes to characterize benchmark reference materials</article-title>
        <source>Sci Data</source>
        <year>2016</year>
        <volume>3</volume>
        <issue>1</issue>
        <fpage>1</fpage>
        <lpage>26</lpage>
      </element-citation>
    </ref>
    <ref id="CR23">
      <label>23.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tommaso</surname>
            <given-names>PD</given-names>
          </name>
          <name>
            <surname>Chatzou</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Floden</surname>
            <given-names>EW</given-names>
          </name>
          <name>
            <surname>Barja</surname>
            <given-names>PP</given-names>
          </name>
          <name>
            <surname>Palumbo</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Notredame</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>Nextflow enables reproducible computational workflows</article-title>
        <source>Nat Biotechnol</source>
        <year>2017</year>
        <volume>35</volume>
        <issue>4</issue>
        <fpage>316</fpage>
        <lpage>319</lpage>
        <?supplied-pmid 28398311?>
        <pub-id pub-id-type="pmid">28398311</pub-id>
      </element-citation>
    </ref>
    <ref id="CR24">
      <label>24.</label>
      <mixed-citation publication-type="other">Mölder F, Jablonski KP, Letcher B, et al. Sustainable data analysis with Snakemake [version 2; peer review: 2 approved]. F1000Research. 2021;10:33.</mixed-citation>
    </ref>
    <ref id="CR25">
      <label>25.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Van der Auwera </surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>O’Connor</surname>
            <given-names>B</given-names>
          </name>
        </person-group>
        <source>Genomics in the cloud: Using Docker, GATK, and WDL in Terra. 1st ed. </source>
        <year>2020</year>
        <publisher-name>O’Reilly Media</publisher-name>
      </element-citation>
    </ref>
    <ref id="CR26">
      <label>26.</label>
      <mixed-citation publication-type="other">Illumina, Inc. DRAGMAP. 2019. [Accessed Summer 2022]. Available from: <ext-link ext-link-type="uri" xlink:href="https://github.com/Illumina/DRAGMAP">https://github.com/Illumina/DRAGMAP</ext-link>.
</mixed-citation>
    </ref>
    <ref id="CR27">
      <label>27.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Szolek</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Schubert</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Mohr</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Sturm</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kohlbacher</surname>
            <given-names>O</given-names>
          </name>
        </person-group>
        <article-title>OptiType: Precision HLA typing from next-generation sequencing data</article-title>
        <source>Bioinforma Oxf Engl</source>
        <year>2014</year>
        <volume>30</volume>
        <issue>23</issue>
        <fpage>3310</fpage>
        <lpage>3316</lpage>
      </element-citation>
    </ref>
    <ref id="CR28">
      <label>28.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Danecek</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Bonfield</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Twelve years of SAMtools and BCFtools</article-title>
        <source>Gigascience</source>
        <year>2021</year>
        <volume>10</volume>
        <issue>2</issue>
        <fpage>008</fpage>
      </element-citation>
    </ref>
    <ref id="CR29">
      <label>29.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Flickinger</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Gagliano </surname>
            <given-names>Taliun S</given-names>
          </name>
          <collab>InPSYght Psychiatric Genetics Consortium</collab>
          <name>
            <surname>Abecasis</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Scott</surname>
            <given-names>L</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Ancestry-agnostic estimation of DNA sample contamination from sequence reads</article-title>
        <source>Genomic Res</source>
        <year>2020</year>
        <volume>30</volume>
        <issue>2</issue>
        <fpage>185</fpage>
        <lpage>94</lpage>
      </element-citation>
    </ref>
    <ref id="CR30">
      <label>30.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Purcell</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Neale</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Todd-Brown</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Thomas</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Ferreira</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Bender</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>Plink: A tool set for whole-genome association and population-based linkage analyses</article-title>
        <source>Am J Hum Genet</source>
        <year>2007</year>
        <volume>81</volume>
        <issue>3</issue>
        <fpage>559</fpage>
        <lpage>575</lpage>
        <?supplied-pmid 17701901?>
        <pub-id pub-id-type="pmid">17701901</pub-id>
      </element-citation>
    </ref>
    <ref id="CR31">
      <label>31.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jin</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Schaffer</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Feolo</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Holmes</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Kattman</surname>
            <given-names>B</given-names>
          </name>
        </person-group>
        <article-title>GRAF-pop: A fast distance-based method to infer subject ancetry from multiple genotype datasets without principal components analysis</article-title>
        <source>G3 Bethesda Md.</source>
        <year>2019</year>
        <volume>9</volume>
        <issue>8</issue>
        <fpage>2447</fpage>
        <lpage>61</lpage>
        <?supplied-pmid 31151998?>
        <pub-id pub-id-type="pmid">31151998</pub-id>
      </element-citation>
    </ref>
    <ref id="CR32">
      <label>32.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jin</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Schaffer</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Sherry</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Feolo</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Quickly identifying identical and closely related subjects in large databases using genotype data</article-title>
        <source>PLoS ONE</source>
        <year>2017</year>
        <volume>12</volume>
        <issue>6</issue>
        <fpage>e0179106</fpage>
        <?supplied-pmid 28609482?>
        <pub-id pub-id-type="pmid">28609482</pub-id>
      </element-citation>
    </ref>
    <ref id="CR33">
      <label>33.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chang</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Chow</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Tellier</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Vattikuti</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Purcell</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Second-generation PLINK: Rising to the challenge of larger and richer datasets</article-title>
        <source>Gigascience</source>
        <year>2015</year>
        <volume>4</volume>
        <issue>7</issue>
        <fpage>13742</fpage>
        <lpage>13815</lpage>
      </element-citation>
    </ref>
    <ref id="CR34">
      <label>34.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <collab>R Core Team</collab>
        </person-group>
        <source>R: A language and environment for statistical computing</source>
        <year>2022</year>
      </element-citation>
    </ref>
    <ref id="CR35">
      <label>35.</label>
      <mixed-citation publication-type="other">Roslin N, Weili L, Paterson A, Strug L. Quality control analysis of the 1000 Genome Project Omni2,5 genotypes. bioRxiv. 2016. 10.1101/078600v1.
</mixed-citation>
    </ref>
    <ref id="CR36">
      <label>36.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <collab>The 1000 Genomes Project Consortium</collab>
        </person-group>
        <article-title>A global reference for human genetic variation</article-title>
        <source>Nature</source>
        <year>2015</year>
        <volume>526</volume>
        <fpage>68</fpage>
        <lpage>74</lpage>
        <pub-id pub-id-type="pmid">26432245</pub-id>
      </element-citation>
    </ref>
    <ref id="CR37">
      <label>37.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Meyer</surname>
            <given-names>HV</given-names>
          </name>
        </person-group>
        <source>meyer-lab-cshl/plinkQC: plinkQC 0.3.2</source>
        <year>2020</year>
      </element-citation>
    </ref>
    <ref id="CR38">
      <label>38.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tremblay</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Rousseau</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Zawati</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Auld</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Chasse</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Coderre</surname>
            <given-names>D</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The Biobanque quebecoise de la COVID-19 (BQC19)–a cohort to prospectively study the clinical and biological determinants of COVID-19 clinical trajectories</article-title>
        <source>PLOS ONE</source>
        <year>2021</year>
        <volume>16</volume>
        <issue>5</issue>
        <fpage>e0245031</fpage>
        <?supplied-pmid 34010280?>
        <pub-id pub-id-type="pmid">34010280</pub-id>
      </element-citation>
    </ref>
    <ref id="CR39">
      <label>39.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Dursi</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Bozoky</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>de Borja</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Lipski</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Brudno</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Federated network across Canada for multi-omic and health data discovery and analysis</article-title>
        <source>Cell Genomics</source>
        <year>2021</year>
        <volume>1</volume>
        <issue>2</issue>
        <fpage>100033</fpage>
        <?supplied-pmid 36778585?>
        <pub-id pub-id-type="pmid">36778585</pub-id>
      </element-citation>
    </ref>
    <ref id="CR40">
      <label>40.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fiume</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Cupak</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Keenan</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Rambla</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>de la Torre</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Dyke</surname>
            <given-names>S</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Federated discovery and sharing of genomic data using Beacons</article-title>
        <source>Nat Biotechnol</source>
        <year>2019</year>
        <volume>37</volume>
        <issue>3</issue>
        <fpage>220</fpage>
        <lpage>224</lpage>
        <?supplied-pmid 30833764?>
        <pub-id pub-id-type="pmid">30833764</pub-id>
      </element-citation>
    </ref>
    <ref id="CR41">
      <label>41.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lin</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Zeng</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>Proper analysis of secondary phenotype data in case-control association studies</article-title>
        <source>Genet Epidemiol</source>
        <year>2009</year>
        <volume>33</volume>
        <issue>3</issue>
        <fpage>256</fpage>
        <lpage>265</lpage>
        <?supplied-pmid 19051285?>
        <pub-id pub-id-type="pmid">19051285</pub-id>
      </element-citation>
    </ref>
    <ref id="CR42">
      <label>42.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ma</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Blackwell</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Boehnke</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Scott</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>Recommended joint and meta-analysis strategies for case-control association testing of single low-count variants</article-title>
        <source>Genet Epidemiol</source>
        <year>2013</year>
        <volume>37</volume>
        <issue>6</issue>
        <fpage>539</fpage>
        <lpage>550</lpage>
        <?supplied-pmid 23788246?>
        <pub-id pub-id-type="pmid">23788246</pub-id>
      </element-citation>
    </ref>
    <ref id="CR43">
      <label>43.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>DG</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Min</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>Relative efficiency of using summary versus individual data in random-effects meta-analysis</article-title>
        <source>Biometrics</source>
        <year>2020</year>
        <volume>76</volume>
        <issue>4</issue>
        <fpage>1319</fpage>
        <lpage>1329</lpage>
        <?supplied-pmid 32056197?>
        <pub-id pub-id-type="pmid">32056197</pub-id>
      </element-citation>
    </ref>
    <ref id="CR44">
      <label>44.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kraft</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Yen</surname>
            <given-names>YC</given-names>
          </name>
          <name>
            <surname>Stram</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Morrison</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Gauderman</surname>
            <given-names>W</given-names>
          </name>
        </person-group>
        <article-title>Exploiting gene-environment interactions to detect genetic associations</article-title>
        <source>Hum Hered</source>
        <year>2007</year>
        <volume>63</volume>
        <issue>2</issue>
        <fpage>111</fpage>
        <lpage>119</lpage>
        <?supplied-pmid 17283440?>
        <pub-id pub-id-type="pmid">17283440</pub-id>
      </element-citation>
    </ref>
    <ref id="CR45">
      <label>45.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Griffith</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Collider bias undermines our understanding of COVID-19 disease risk and severity</article-title>
        <source>Nat Commun</source>
        <year>2020</year>
        <volume>11</volume>
        <issue>1</issue>
        <fpage>1</fpage>
        <lpage>12</lpage>
        <pub-id pub-id-type="pmid">31911652</pub-id>
      </element-citation>
    </ref>
    <ref id="CR46">
      <label>46.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tao</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Zeng</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Franceschini</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>North</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Boerwinkle</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>DY</given-names>
          </name>
        </person-group>
        <article-title>Analysis of sequence data under multivariate trait-dependent sampling</article-title>
        <source>J Am Stat Assoc</source>
        <year>2015</year>
        <volume>110</volume>
        <issue>510</issue>
        <fpage>560</fpage>
        <lpage>572</lpage>
        <?supplied-pmid 26366025?>
        <pub-id pub-id-type="pmid">26366025</pub-id>
      </element-citation>
    </ref>
    <ref id="CR47">
      <label>47.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lawless</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Kalbfleisch</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Wild</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>Semiparametric methods for response-selective and missing data problems in regression</article-title>
        <source>Stat Methodol Ser B</source>
        <year>1999</year>
        <volume>61</volume>
        <issue>2</issue>
        <fpage>413</fpage>
        <lpage>438</lpage>
      </element-citation>
    </ref>
    <ref id="CR48">
      <label>48.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Huang</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>Efficient association mapping of quantitative trait loci with selective genotyping</article-title>
        <source>Am J Hum Genet</source>
        <year>2007</year>
        <volume>80</volume>
        <fpage>567</fpage>
        <lpage>576</lpage>
        <?supplied-pmid 17273979?>
        <pub-id pub-id-type="pmid">17273979</pub-id>
      </element-citation>
    </ref>
    <ref id="CR49">
      <label>49.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Monsees</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Tamimi</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Kraft</surname>
            <given-names>P</given-names>
          </name>
        </person-group>
        <article-title>Genome-wide association scans for secondary traits using case-control samples</article-title>
        <source>Genet Epidemiol</source>
        <year>2009</year>
        <volume>33</volume>
        <issue>8</issue>
        <fpage>717</fpage>
        <lpage>728</lpage>
        <?supplied-pmid 19365863?>
        <pub-id pub-id-type="pmid">19365863</pub-id>
      </element-citation>
    </ref>
    <ref id="CR50">
      <label>50.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tounkara</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Lefebvre</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Greenwood</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Oualkacha</surname>
            <given-names>K</given-names>
          </name>
        </person-group>
        <article-title>A flexible copula-based approach for the analysis of secondary phenotypes in ascertained samples</article-title>
        <source>Stat Med</source>
        <year>2020</year>
        <volume>39</volume>
        <issue>5</issue>
        <fpage>517</fpage>
        <lpage>543</lpage>
        <?supplied-pmid 31868965?>
        <pub-id pub-id-type="pmid">31868965</pub-id>
      </element-citation>
    </ref>
    <ref id="CR51">
      <label>51.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gail</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Wieand</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Piantadosi</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Biased estimates of treatment effect in randomized experiments with nonlinear regression and omitted covariates</article-title>
        <source>Biometrika</source>
        <year>1984</year>
        <volume>71</volume>
        <issue>3</issue>
        <fpage>431</fpage>
        <lpage>444</lpage>
      </element-citation>
    </ref>
    <ref id="CR52">
      <label>52.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pirinen</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Donnelly</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Spencer</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>Including known covariates can reduce power to detect genetic effects in case-control studies</article-title>
        <source>Nat Genet</source>
        <year>2012</year>
        <volume>44</volume>
        <issue>8</issue>
        <fpage>848</fpage>
        <lpage>851</lpage>
        <?supplied-pmid 22820511?>
        <pub-id pub-id-type="pmid">22820511</pub-id>
      </element-citation>
    </ref>
    <ref id="CR53">
      <label>53.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Herridge</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Cheung</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Tansey</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Matte-Martyn</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Diaz-Granados</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Al-Saidi</surname>
            <given-names>F</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>One-year outcomes in survivors of the acute respiratory distress syndrome</article-title>
        <source>N Engl J Med</source>
        <year>2003</year>
        <volume>348</volume>
        <issue>8</issue>
        <fpage>683</fpage>
        <lpage>693</lpage>
        <?supplied-pmid 12594312?>
        <pub-id pub-id-type="pmid">12594312</pub-id>
      </element-citation>
    </ref>
    <ref id="CR54">
      <label>54.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lederer</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Bell</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Branson</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Chalmers</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Marshall</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Maslove</surname>
            <given-names>D</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Control of confounding and reporting of results in causal inference studies. Guidance for authors from editors of respiratory, sleep, and critical care journals</article-title>
        <source>Ann Am Thorac Soc</source>
        <year>2019</year>
        <volume>16</volume>
        <issue>1</issue>
        <fpage>22</fpage>
        <lpage>8</lpage>
        <?supplied-pmid 30230362?>
        <pub-id pub-id-type="pmid">30230362</pub-id>
      </element-citation>
    </ref>
    <ref id="CR55">
      <label>55.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Aschard</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Vilhjalmsson</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Joshi</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Price</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Kraft</surname>
            <given-names>P</given-names>
          </name>
        </person-group>
        <article-title>Adjusting for heritable covariates can bias effect estimates in Genome-Wide Association Studies</article-title>
        <source>Am J Hum Genet</source>
        <year>2015</year>
        <volume>96</volume>
        <issue>2</issue>
        <fpage>329</fpage>
        <lpage>339</lpage>
        <?supplied-pmid 25640676?>
        <pub-id pub-id-type="pmid">25640676</pub-id>
      </element-citation>
    </ref>
    <ref id="CR56">
      <label>56.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Peckham</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>de Gruijter</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Raine</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Radzisweska</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Ciurtin</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Wedderburn</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission</article-title>
        <source>Nat Commun</source>
        <year>2020</year>
        <volume>11</volume>
        <issue>1</issue>
        <fpage>1</fpage>
        <lpage>10</lpage>
        <pub-id pub-id-type="pmid">31911652</pub-id>
      </element-citation>
    </ref>
    <ref id="CR57">
      <label>57.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Vahidy</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Pan</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Ahnstedt</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Munshi</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Choi</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Tiruneh</surname>
            <given-names>Y</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Sex differences in susceptibility, severity, and outcomes of coronavirus disease 2019: Cross-sectional analysis from a diverse US metropolitan area</article-title>
        <source>PLoS ONE</source>
        <year>2021</year>
        <volume>16</volume>
        <issue>1</issue>
        <fpage>e0245556</fpage>
        <?supplied-pmid 33439908?>
        <pub-id pub-id-type="pmid">33439908</pub-id>
      </element-citation>
    </ref>
    <ref id="CR58">
      <label>58.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pradhan</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Olasson</surname>
            <given-names>PE</given-names>
          </name>
        </person-group>
        <article-title>Sex differences in severity and mortality from COVID-19: Are males more vulnerable?</article-title>
        <source>Biol Sex Differ</source>
        <year>2020</year>
        <volume>11</volume>
        <fpage>53</fpage>
        <?supplied-pmid 32948238?>
        <pub-id pub-id-type="pmid">32948238</pub-id>
      </element-citation>
    </ref>
    <ref id="CR59">
      <label>59.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Song</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Biernacka</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Winham</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Testing and estimation of X-chromosome SNP effects: Impact of model assumptions</article-title>
        <source>Genet Epidemiol</source>
        <year>2021</year>
        <volume>45</volume>
        <issue>6</issue>
        <fpage>577</fpage>
        <lpage>592</lpage>
        <?supplied-pmid 34082482?>
        <pub-id pub-id-type="pmid">34082482</pub-id>
      </element-citation>
    </ref>
    <ref id="CR60">
      <label>60.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tukiainen</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Villani</surname>
            <given-names>AC</given-names>
          </name>
          <name>
            <surname>Yen</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Rivas</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Marshall</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Satija</surname>
            <given-names>R</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Landscape of X chromosome inactivation across human tissues</article-title>
        <source>Nature</source>
        <year>2017</year>
        <volume>550</volume>
        <issue>7675</issue>
        <fpage>244</fpage>
        <lpage>248</lpage>
        <?supplied-pmid 29022598?>
        <pub-id pub-id-type="pmid">29022598</pub-id>
      </element-citation>
    </ref>
    <ref id="CR61">
      <label>61.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>X</given-names>
          </name>
        </person-group>
        <article-title>Optimal tests for rare variant effects in sequencing association studies</article-title>
        <source>Biostatistics</source>
        <year>2012</year>
        <volume>13</volume>
        <issue>4</issue>
        <fpage>762</fpage>
        <lpage>775</lpage>
        <?supplied-pmid 22699862?>
        <pub-id pub-id-type="pmid">22699862</pub-id>
      </element-citation>
    </ref>
    <ref id="CR62">
      <label>62.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Talluri</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Shete</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Selection of X-chromosome inactivation model</article-title>
        <source>Cancer Inform</source>
        <year>2017</year>
        <volume>16</volume>
        <fpage>1</fpage>
        <lpage>8</lpage>
        <pub-id pub-id-type="pmid">28096648</pub-id>
      </element-citation>
    </ref>
    <ref id="CR63">
      <label>63.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Craiu</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>Bayesian model averaging for the X-chromosome inactivation dilemma in genetic association study</article-title>
        <source>Biostatistics</source>
        <year>2020</year>
        <volume>21</volume>
        <issue>2</issue>
        <fpage>319</fpage>
        <lpage>335</lpage>
        <?supplied-pmid 30247537?>
        <pub-id pub-id-type="pmid">30247537</pub-id>
      </element-citation>
    </ref>
    <ref id="CR64">
      <label>64.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Craiu</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Strug</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>The X factor: A robust and powerful approach to X-chromosome-inclusive whole-genome association studies</article-title>
        <source>Genet Epidemiol</source>
        <year>2021</year>
        <volume>45</volume>
        <issue>7</issue>
        <fpage>694</fpage>
        <lpage>709</lpage>
        <?supplied-pmid 34224641?>
        <pub-id pub-id-type="pmid">34224641</pub-id>
      </element-citation>
    </ref>
    <ref id="CR65">
      <label>65.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Derkach</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Lawless</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>Pooled association tests for rare genetic variants: A review and some new results</article-title>
        <source>Stat Sci</source>
        <year>2014</year>
        <volume>29</volume>
        <issue>2</issue>
        <fpage>302</fpage>
        <lpage>321</lpage>
      </element-citation>
    </ref>
    <ref id="CR66">
      <label>66.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Abecasis</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Boehnke</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>X</given-names>
          </name>
        </person-group>
        <article-title>Rare-variant association analysis: Study designs and statistical tests</article-title>
        <source>Am J Hum Genet</source>
        <year>2014</year>
        <volume>95</volume>
        <issue>1</issue>
        <fpage>5</fpage>
        <lpage>23</lpage>
        <?supplied-pmid 24995866?>
        <pub-id pub-id-type="pmid">24995866</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName A++V2.4.dtd?>
<?SourceDTD.Version 2.4?>
<?ConverterInfo.XSLTName springer2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">BMC Genom Data</journal-id>
    <journal-id journal-id-type="iso-abbrev">BMC Genom Data</journal-id>
    <journal-title-group>
      <journal-title>BMC Genomic Data</journal-title>
    </journal-title-group>
    <issn pub-type="epub">2730-6844</issn>
    <publisher>
      <publisher-name>BioMed Central</publisher-name>
      <publisher-loc>London</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10152008</article-id>
    <article-id pub-id-type="publisher-id">1128</article-id>
    <article-id pub-id-type="doi">10.1186/s12863-023-01128-3</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Database</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>HostSeq: a Canadian whole genome sequencing and clinical data resource</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" equal-contrib="yes">
        <name>
          <surname>Yoo</surname>
          <given-names>S</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author" equal-contrib="yes">
        <name>
          <surname>Garg</surname>
          <given-names>E</given-names>
        </name>
        <xref ref-type="aff" rid="Aff3">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Elliott</surname>
          <given-names>LT</given-names>
        </name>
        <xref ref-type="aff" rid="Aff3">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Hung</surname>
          <given-names>RJ</given-names>
        </name>
        <xref ref-type="aff" rid="Aff4">4</xref>
        <xref ref-type="aff" rid="Aff5">5</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Halevy</surname>
          <given-names>AR</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Brooks</surname>
          <given-names>JD</given-names>
        </name>
        <xref ref-type="aff" rid="Aff4">4</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Bull</surname>
          <given-names>SB</given-names>
        </name>
        <xref ref-type="aff" rid="Aff4">4</xref>
        <xref ref-type="aff" rid="Aff5">5</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Gagnon</surname>
          <given-names>F</given-names>
        </name>
        <xref ref-type="aff" rid="Aff4">4</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Greenwood</surname>
          <given-names>CMT</given-names>
        </name>
        <xref ref-type="aff" rid="Aff6">6</xref>
        <xref ref-type="aff" rid="Aff7">7</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Lawless</surname>
          <given-names>JF</given-names>
        </name>
        <xref ref-type="aff" rid="Aff8">8</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Paterson</surname>
          <given-names>AD</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff4">4</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Sun</surname>
          <given-names>L</given-names>
        </name>
        <xref ref-type="aff" rid="Aff4">4</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zawati</surname>
          <given-names>MH</given-names>
        </name>
        <xref ref-type="aff" rid="Aff6">6</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Lerner-Ellis</surname>
          <given-names>J</given-names>
        </name>
        <xref ref-type="aff" rid="Aff4">4</xref>
        <xref ref-type="aff" rid="Aff9">9</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Abraham</surname>
          <given-names>RJS</given-names>
        </name>
        <xref ref-type="aff" rid="Aff10">10</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Birol</surname>
          <given-names>I</given-names>
        </name>
        <xref ref-type="aff" rid="Aff10">10</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Bourque</surname>
          <given-names>G</given-names>
        </name>
        <xref ref-type="aff" rid="Aff6">6</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Garant</surname>
          <given-names>J-M</given-names>
        </name>
        <xref ref-type="aff" rid="Aff10">10</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Gosselin</surname>
          <given-names>C</given-names>
        </name>
        <xref ref-type="aff" rid="Aff10">10</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Li</surname>
          <given-names>J</given-names>
        </name>
        <xref ref-type="aff" rid="Aff10">10</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Whitney</surname>
          <given-names>J</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Thiruvahindrapuram</surname>
          <given-names>B</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Herbrick</surname>
          <given-names>J-A</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Lorenti</surname>
          <given-names>M</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Reuter</surname>
          <given-names>MS</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Adeoye</surname>
          <given-names>OO</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Liu</surname>
          <given-names>S</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Allen</surname>
          <given-names>U</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff4">4</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Bernier</surname>
          <given-names>FP</given-names>
        </name>
        <xref ref-type="aff" rid="Aff11">11</xref>
        <xref ref-type="aff" rid="Aff12">12</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Biggs</surname>
          <given-names>CM</given-names>
        </name>
        <xref ref-type="aff" rid="Aff13">13</xref>
        <xref ref-type="aff" rid="Aff14">14</xref>
        <xref ref-type="aff" rid="Aff15">15</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Cheung</surname>
          <given-names>AM</given-names>
        </name>
        <xref ref-type="aff" rid="Aff16">16</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Cowan</surname>
          <given-names>J</given-names>
        </name>
        <xref ref-type="aff" rid="Aff2">2</xref>
        <xref ref-type="aff" rid="Aff17">17</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Herridge</surname>
          <given-names>M</given-names>
        </name>
        <xref ref-type="aff" rid="Aff16">16</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Maslove</surname>
          <given-names>DM</given-names>
        </name>
        <xref ref-type="aff" rid="Aff18">18</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Modi</surname>
          <given-names>BP</given-names>
        </name>
        <xref ref-type="aff" rid="Aff14">14</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Mooser</surname>
          <given-names>V</given-names>
        </name>
        <xref ref-type="aff" rid="Aff6">6</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Morris</surname>
          <given-names>SK</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff4">4</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Ostrowski</surname>
          <given-names>M</given-names>
        </name>
        <xref ref-type="aff" rid="Aff4">4</xref>
        <xref ref-type="aff" rid="Aff19">19</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Parekh</surname>
          <given-names>RS</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff4">4</xref>
        <xref ref-type="aff" rid="Aff20">20</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Pfeffer</surname>
          <given-names>G</given-names>
        </name>
        <xref ref-type="aff" rid="Aff11">11</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Suchowersky</surname>
          <given-names>O</given-names>
        </name>
        <xref ref-type="aff" rid="Aff21">21</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Taher</surname>
          <given-names>J</given-names>
        </name>
        <xref ref-type="aff" rid="Aff4">4</xref>
        <xref ref-type="aff" rid="Aff9">9</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Upton</surname>
          <given-names>J</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff4">4</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Warren</surname>
          <given-names>RL</given-names>
        </name>
        <xref ref-type="aff" rid="Aff10">10</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Yeung</surname>
          <given-names>RSM</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff4">4</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Aziz</surname>
          <given-names>N</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Turvey</surname>
          <given-names>SE</given-names>
        </name>
        <xref ref-type="aff" rid="Aff13">13</xref>
        <xref ref-type="aff" rid="Aff14">14</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Knoppers</surname>
          <given-names>BM</given-names>
        </name>
        <xref ref-type="aff" rid="Aff6">6</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Lathrop</surname>
          <given-names>M</given-names>
        </name>
        <xref ref-type="aff" rid="Aff6">6</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Jones</surname>
          <given-names>SJM</given-names>
        </name>
        <xref ref-type="aff" rid="Aff10">10</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Scherer</surname>
          <given-names>SW</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff4">4</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0503-9740</contrib-id>
        <name>
          <surname>Strug</surname>
          <given-names>LJ</given-names>
        </name>
        <address>
          <email>lisa.strug@utoronto.ca</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff4">4</xref>
      </contrib>
      <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.42327.30</institution-id><institution-id institution-id-type="ISNI">0000 0004 0473 9646</institution-id><institution>The Hospital for Sick Children, </institution></institution-wrap>Toronto, ON Canada </aff>
      <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.28046.38</institution-id><institution-id institution-id-type="ISNI">0000 0001 2182 2255</institution-id><institution>University of Ottawa, </institution></institution-wrap>Ottawa, ON Canada </aff>
      <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.61971.38</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7494</institution-id><institution>Simon Fraser University, </institution></institution-wrap>Burnaby, BC Canada </aff>
      <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.17063.33</institution-id><institution-id institution-id-type="ISNI">0000 0001 2157 2938</institution-id><institution>University of Toronto, </institution></institution-wrap>Toronto, ON Canada </aff>
      <aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.250674.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 0626 6184</institution-id><institution>Lunenfeld-Tanenbaum Research Institute, Sinai Health, </institution></institution-wrap>Toronto, ON Canada </aff>
      <aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.14709.3b</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8649</institution-id><institution>McGill University, </institution></institution-wrap>Montreal, QC Canada </aff>
      <aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="GRID">grid.414980.0</institution-id><institution-id institution-id-type="ISNI">0000 0000 9401 2774</institution-id><institution>Lady Davis Institute for Medical Research, Jewish General Hospital, </institution></institution-wrap>Montreal, QC Canada </aff>
      <aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="GRID">grid.46078.3d</institution-id><institution-id institution-id-type="ISNI">0000 0000 8644 1405</institution-id><institution>University of Waterloo, </institution></institution-wrap>Waterloo, ON Canada </aff>
      <aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="GRID">grid.492573.e</institution-id><institution-id institution-id-type="ISNI">0000 0004 6477 6457</institution-id><institution>Sinai Health System, </institution></institution-wrap>Toronto, ON Canada </aff>
      <aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="GRID">grid.434706.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 0410 5424</institution-id><institution>Canada’s Michael Smith Genome Sciences Centre, </institution></institution-wrap>Vancouver, BC Canada </aff>
      <aff id="Aff11"><label>11</label><institution-wrap><institution-id institution-id-type="GRID">grid.22072.35</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7697</institution-id><institution>University of Calgary, </institution></institution-wrap>Calgary, AB Canada </aff>
      <aff id="Aff12"><label>12</label><institution-wrap><institution-id institution-id-type="GRID">grid.413571.5</institution-id><institution-id institution-id-type="ISNI">0000 0001 0684 7358</institution-id><institution>Alberta Children’s Hospital, </institution></institution-wrap>Calgary, AB Canada </aff>
      <aff id="Aff13"><label>13</label><institution-wrap><institution-id institution-id-type="GRID">grid.17091.3e</institution-id><institution-id institution-id-type="ISNI">0000 0001 2288 9830</institution-id><institution>University of British Columbia, </institution></institution-wrap>Vancouver, BC Canada </aff>
      <aff id="Aff14"><label>14</label><institution-wrap><institution-id institution-id-type="GRID">grid.414137.4</institution-id><institution-id institution-id-type="ISNI">0000 0001 0684 7788</institution-id><institution>BC Children’s Hospital, </institution></institution-wrap>Vancouver, BC Canada </aff>
      <aff id="Aff15"><label>15</label><institution-wrap><institution-id institution-id-type="GRID">grid.416553.0</institution-id><institution-id institution-id-type="ISNI">0000 0000 8589 2327</institution-id><institution>St. Paul’s Hospital, </institution></institution-wrap>Vancouver, BC Canada </aff>
      <aff id="Aff16"><label>16</label><institution-wrap><institution-id institution-id-type="GRID">grid.231844.8</institution-id><institution-id institution-id-type="ISNI">0000 0004 0474 0428</institution-id><institution>University Health Network, </institution></institution-wrap>Toronto, ON Canada </aff>
      <aff id="Aff17"><label>17</label><institution-wrap><institution-id institution-id-type="GRID">grid.412687.e</institution-id><institution-id institution-id-type="ISNI">0000 0000 9606 5108</institution-id><institution>The Ottawa Hospital Research Institute, </institution></institution-wrap>Ottawa, ON Canada </aff>
      <aff id="Aff18"><label>18</label><institution-wrap><institution-id institution-id-type="GRID">grid.410356.5</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8331</institution-id><institution>Queen’s University, </institution></institution-wrap>Kingston, ON Canada </aff>
      <aff id="Aff19"><label>19</label><institution-wrap><institution-id institution-id-type="GRID">grid.415502.7</institution-id><institution>St. Michael’s Hospital, Unity Health, </institution></institution-wrap>Toronto, ON Canada </aff>
      <aff id="Aff20"><label>20</label><institution-wrap><institution-id institution-id-type="GRID">grid.417199.3</institution-id><institution-id institution-id-type="ISNI">0000 0004 0474 0188</institution-id><institution>Women’s College Hospital, </institution></institution-wrap>Toronto, ON Canada </aff>
      <aff id="Aff21"><label>21</label><institution-wrap><institution-id institution-id-type="GRID">grid.17089.37</institution-id><institution-id institution-id-type="ISNI">0000 0001 2190 316X</institution-id><institution>University of Alberta, </institution></institution-wrap>Edmonton, AB Canada </aff>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>2</day>
      <month>5</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>2</day>
      <month>5</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2023</year>
    </pub-date>
    <volume>24</volume>
    <elocation-id>26</elocation-id>
    <history>
      <date date-type="received">
        <day>15</day>
        <month>6</month>
        <year>2022</year>
      </date>
      <date date-type="accepted">
        <day>22</day>
        <month>2</month>
        <year>2023</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2023</copyright-statement>
      <license>
        <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p>
      </license>
    </permissions>
    <abstract id="Abs1">
      <p id="Par1">HostSeq was launched in April 2020 as a national initiative to integrate whole genome sequencing data from 10,000 Canadians infected with SARS-CoV-2 with clinical information related to their disease experience. The mandate of HostSeq is to support the Canadian and international research communities in their efforts to understand the risk factors for disease and associated health outcomes and support the development of interventions such as vaccines and therapeutics. HostSeq is a collaboration among 13 independent epidemiological studies of SARS-CoV-2 across five provinces in Canada. Aggregated data collected by HostSeq are made available to the public through two data portals: a phenotype portal showing summaries of major variables and their distributions, and a variant search portal enabling queries in a genomic region. Individual-level data is available to the global research community for health research through a Data Access Agreement and Data Access Compliance Office approval. Here we provide an overview of the collective project design along with summary level information for HostSeq. We highlight several statistical considerations for researchers using the HostSeq platform regarding data aggregation, sampling mechanism, covariate adjustment, and X chromosome analysis. In addition to serving as a rich data source, the diversity of study designs, sample sizes, and research objectives among the participating studies provides unique opportunities for the research community.
</p>
      <sec>
        <title>Supplementary Information</title>
        <p>The online version contains supplementary material available at 10.1186/s12863-023-01128-3.</p>
      </sec>
    </abstract>
    <kwd-group xml:lang="en">
      <title>Keywords</title>
      <kwd>SARS-CoV-2</kwd>
      <kwd>COVID-19</kwd>
      <kwd>Host genetics</kwd>
      <kwd>Clinical databank</kwd>
      <kwd>Whole genome sequencing</kwd>
    </kwd-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100008762</institution-id>
            <institution>Genome Canada</institution>
          </institution-wrap>
        </funding-source>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100011332</institution-id>
            <institution>Innovation, Science and Economic Development Canada</institution>
          </institution-wrap>
        </funding-source>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>PHAC</institution>
        </funding-source>
        <award-id>2021-HQ-000051</award-id>
        <principal-award-recipient>
          <name>
            <surname>Mooser</surname>
            <given-names>V</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>FRQ-S</institution>
        </funding-source>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100013062</institution-id>
            <institution>Génome Québec</institution>
          </institution-wrap>
        </funding-source>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000024</institution-id>
            <institution>Canadian Institutes of Health Research</institution>
          </institution-wrap>
        </funding-source>
        <award-id>GA4-177739</award-id>
        <award-id>MM1-181123</award-id>
        <award-id>447643</award-id>
        <award-id>VR4-172753</award-id>
        <award-id>461170</award-id>
        <award-id>461304</award-id>
        <principal-award-recipient>
          <name>
            <surname>Lerner-Ellis</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Cheung</surname>
            <given-names>AM</given-names>
          </name>
          <name>
            <surname>Yeung</surname>
            <given-names>RSM</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>COVID-19 Immunity Task Force</institution>
        </funding-source>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100021784</institution-id>
            <institution>Ministry of Colleges and Universities</institution>
          </institution-wrap>
        </funding-source>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>Genome Alberta</institution>
        </funding-source>
        <award-id>RRP2</award-id>
        <principal-award-recipient>
          <name>
            <surname>Bernier</surname>
            <given-names>FP</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>Alberta Children’s Hospital</institution>
        </funding-source>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>Mitogen DX</institution>
        </funding-source>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>SickKids Foundation</institution>
        </funding-source>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>University of Toronto</institution>
        </funding-source>
        <award-id>508791</award-id>
        <principal-award-recipient>
          <name>
            <surname>Allen</surname>
            <given-names>U</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000233</institution-id>
            <institution>Genome British Columbia</institution>
          </institution-wrap>
        </funding-source>
        <award-id>COV199</award-id>
        <principal-award-recipient>
          <name>
            <surname>Turvey</surname>
            <given-names>SE</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100010661</institution-id>
            <institution>Southeastern Ontario Academic Medical Organization</institution>
          </institution-wrap>
        </funding-source>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>Providence Healthcare Research Institute </institution>
        </funding-source>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>CFI</institution>
        </funding-source>
        <award-id>HSC0005268/6220200122</award-id>
        <principal-award-recipient>
          <name>
            <surname>Yeung</surname>
            <given-names>RSM</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009003</institution-id>
            <institution>Hotchkiss Brain Institute, University of Calgary</institution>
          </institution-wrap>
        </funding-source>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100012866</institution-id>
            <institution>Cumming School of Medicine, University of Calgary</institution>
          </institution-wrap>
        </funding-source>
      </award-group>
    </funding-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>issue-copyright-statement</meta-name>
        <meta-value>© The Author(s) 2023</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="Sec1">
    <title>Background</title>
    <p id="Par2">Following exposure to SARS-CoV-2 (the virus that causes COVID-19), some individuals remain disease- or symptom-free while others develop a spectrum of symptoms from mild to severe with the potential for fatal outcomes [<xref ref-type="bibr" rid="CR1">1</xref>]. This variability in response to exposure suggests that susceptibility is mediated at least in part by host genetic factors [<xref ref-type="bibr" rid="CR2">2</xref>]. Genetic factors have been associated with acquisition and severity of other viral infections [<xref ref-type="bibr" rid="CR3">3</xref>–<xref ref-type="bibr" rid="CR7">7</xref>], including SARS-CoV-1 [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>]. A growing body of work demonstrates a role for host genetics in SARS-CoV-2 [<xref ref-type="bibr" rid="CR10">10</xref>–<xref ref-type="bibr" rid="CR14">14</xref>]. Despite the relative novelty of the SARS-CoV-2 virus and the challenges of identifying genetic contributors in a changing environment [<xref ref-type="bibr" rid="CR2">2</xref>], several loci contributing to infection susceptibility and illness severity have been identified [<xref ref-type="bibr" rid="CR15">15</xref>]. Associated loci are comprised of rare and common variations and occur throughout the genome, including but not limited to chromosome X and the HLA region on chromosome 6.</p>
    <p id="Par3">In 2020, several countries launched efforts to identify the genetic factors affecting COVID-19 outcomes to support diagnostics, therapy and vaccine development. However, Canada was not poised to do so because, although population-based cohorts exist [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>], a national whole genome sequencing cohort broadly consented for research and translation, and linked to rich clinical and public health data, did not exist at the onset of the global pandemic. Here we describe the development of this national platform to address pressing questions concerning COVID-19 and other health outcomes in Canada. In April 2020, as part of the Canadian pandemic response, Genome Canada (a not-for-profit organization funded by the Government of Canada) launched the Canadian COVID-19 Genomics Network (CanCOGeN; [<xref ref-type="bibr" rid="CR18">18</xref>]). CanCOGeN established a coordinated pan-Canadian network of studies in collaboration with Canada’s national platform for genome sequencing and analysis (CGEn). Beginning June 2020, CGEn developed HostSeq: a national databank of independent clinical and epidemiological studies enrolling SARS-CoV-2-infected participants across Canada. The goal of HostSeq is to create a data repository with whole genome sequencing and harmonized clinical information, including comorbidities for 10,000 Canadians. With the launch of HostSeq, investigators can now begin to address questions of genetic susceptibility to SARS-CoV-2 infection and outcomes from the Canadian perspective. The approvals in place to link HostSeq to other local, provincial or national data resources expand the utility of the resource, including genetic susceptibility for future implications of SARS-CoV-2 infection. Further, summary statistics from association studies of HostSeq have been contributed and are aligned with international efforts including the COVID-19 Host Genetic Initiative (HGI; [<xref ref-type="bibr" rid="CR19">19</xref>]) and COVID Human Genetic Effort (<ext-link ext-link-type="uri" xlink:href="https://www.covidhge.com/">https://www.covidhge.com/</ext-link>). Most importantly, we have established the research project infrastructure necessary for future pan-Canadian genome sequencing studies. In this resource paper introducing the HostSeq Databank, we present its design characteristics, high-level analytic considerations pertaining to it, and the research opportunities this rich resource provides.</p>
  </sec>
  <sec id="Sec2">
    <title>Construction and content</title>
    <sec id="Sec3">
      <title>HostSeq project design</title>
      <p id="Par4">HostSeq (Fig. <xref rid="Fig1" ref-type="fig">1</xref>) is a project representing a consortium of investigator-initiated SARS-CoV-2-related research studies across Canada. Each partner study was required to adhere to core consent elements (Table S<xref rid="MOESM1" ref-type="media">1</xref>), contribute blood (or in rare cases saliva) samples for whole genome sequencing, and provide clinical information using a standardized case report form (Table S<xref rid="MOESM1" ref-type="media">2</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><p>Sample and data flow in HostSeq (Aspects of graphics acquired from Wikimedia Commons)</p></caption><graphic xlink:href="12863_2023_1128_Fig1_HTML" id="MO1"/></fig></p>
      <p id="Par5">Within these studies, eligible participants include individuals of any age with a positive SARS-CoV-2 test performed by any Health Canada approved method. In some studies, suspected cases with clinically assessed COVID-19-related symptoms but without a positive test diagnosis were also included. Within the primary studies, each participant consented to use of their whole genome sequence for future research [<xref ref-type="bibr" rid="CR20">20</xref>]. Participants also consented to the update, linkage and collection of their data from medical records and charts, as well as from administrative databases, and the deposition of data in a cloud-based, access-controlled databank which can be shared with approved researchers including international and commercial researchers. Additionally, participants had the option to consent to be re-contacted for updates or additional health information, or for invitations to participate in new research. Informed consent was obtained from individuals at each of the participating study sites. For the HostSeq Databank, approval was sought from the study’s Research Ethics Board (REB) for inclusion in HostSeq.</p>
      <p id="Par6">The HostSeq Databank shares data with the global research community following review and approval by the HostSeq-independent Data Access Compliance Office (DACO), as described below in the <italic>Availability of Data and Materials</italic> section.</p>
    </sec>
    <sec id="Sec4">
      <title>Whole genome sequencing</title>
      <p id="Par7">All HostSeq samples undergo whole genome sequencing in a standardized fashion at one of the three CGEn nodes: Toronto (The Centre for Applied Genomics at The Hospital for Sick Children), Montréal (McGill Genome Centre at McGill University), and Vancouver (Canada’s Michael Smith Genome Sciences Centre) on the Illumina NovaSeq6000 platform at 30X depth. Prior to sequencing, quality assurance is performed at multiple stages throughout the process [<xref ref-type="bibr" rid="CR21">21</xref>]. Concordance of the genotyping pipeline among sequencing sites is verified using the Ashkenazi trio set from the Genome in a Bottle Consortium [<xref ref-type="bibr" rid="CR22">22</xref>].</p>
      <p id="Par8">Sequenced samples are analyzed jointly using an in-house pipeline encoded in Nextflow [<xref ref-type="bibr" rid="CR23">23</xref>] and Snakemake [<xref ref-type="bibr" rid="CR24">24</xref>], containerized using Docker [<xref ref-type="bibr" rid="CR25">25</xref>]. The Genome Reference Consortium human build 38 (GRCh38 assembly version GCA_000001405.15) reference genome that includes the alternative HLA decoy genes<xref ref-type="fn" rid="Fn1">1</xref> is used. Genomes are processed following the Best Practices guidelines of the Genome Analysis ToolKit (GATK v4.2.5.0). This includes alignment of sequences to the reference genome, and the genotyping of each sample individually followed by joint-calling of all genotypes together. Associated scripts can be found in a public repository (<ext-link ext-link-type="uri" xlink:href="https://svn.bcgsc.ca/bitbucket/users/jmgarant">https://svn.bcgsc.ca/bitbucket/users/jmgarant</ext-link>). Software packages used to process and analyze the WGS data are listed in Table S<xref rid="MOESM1" ref-type="media">3</xref>.</p>
      <p id="Par9">The in-house pipeline is as follows. Sequences are aligned to the reference genome using DRAGEN mapper (DRAGMAP v1.3.0; [<xref ref-type="bibr" rid="CR26">26</xref>]), sorted with Picard tools (v2.25.0) and bases are recalibrated using the Base Quality Score Recalibration (BQSR) of GATK. GATK HaplotypeCaller is used in Dragen mode on diploid samples for short variant discovery. Aligned sequences are thus converted to genomic Variant Calling Format (gVCF) files, which are then filtered and imported to a GATK GenomicsDB for joint-calling using the GATK GenotypeGVCFs tool. We perform HLA Class I typing using OptiType software (v1.3.1; [<xref ref-type="bibr" rid="CR27">27</xref>]); perform housekeeping with bcftools (v1.11) and samtools (v1.14; [<xref ref-type="bibr" rid="CR28">28</xref>]); check for sample contamination using VerifyBamID2 (v2.0.1) [<xref ref-type="bibr" rid="CR29">29</xref>]; check agreement between reported sex-at-birth and sex chromosome composition using PLINK software (v1.90; [<xref ref-type="bibr" rid="CR30">30</xref>]); and predict ancestry admixture [<xref ref-type="bibr" rid="CR31">31</xref>] and relatedness [<xref ref-type="bibr" rid="CR32">32</xref>] using Genetic Relationship and Fingerprinting software (GRAF v2.4). We use PLINK (v2.00; [<xref ref-type="bibr" rid="CR33">33</xref>]) and R (3.6.3; [<xref ref-type="bibr" rid="CR34">34</xref>]) for genetic data analysis. Additionally, we compare the genetic principal components of HostSeq with the 1000 Genomes Project reference populations [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR36">36</xref>] following the guidelines of plinkQC [<xref ref-type="bibr" rid="CR37">37</xref>]. Samples are excluded based on the following checks (Figure S<xref rid="MOESM1" ref-type="media">1</xref>): (i) genotyping call rate &lt; 95%, (ii) sex chromosome composition and reported sex-at-birth mismatch, (iii) samples identified as duplicates, (iv) possibly mislabelled samples, (v) sample contamination rate &gt; 3%, and (vi) mean coverage &lt; 10. The whole genome sequence data are provided in joint VCF format (aligned sequences can also be obtained).</p>
    </sec>
    <sec id="Sec5">
      <title>Contributing studies and data harmonization</title>
      <p id="Par10">As of December 20, 2022, 13 participating studies contributed data and biospecimens to HostSeq (Table S<xref rid="MOESM1" ref-type="media">4</xref>). Although all 13 studies continue collecting clinical information, 6 have completed their participant recruitment. To date, we have harmonized data from all 13 studies. The participating studies are predominantly prospective SARS-CoV-2 studies based in hospitals, and are seeking to identify genetic factors that contribute to varying COVID-19 outcomes. Here we summarize characteristics of the 13 harmonized studies. Three studies—genMARK, Alberta Childhood COVID-19 Cohort (“AB3C”), and Genomic Determinants of COVID-19 (“GD-COVID”) —are using a case–control design, in which laboratory-confirmed COVID-19 cases are matched with controls (see Table S<xref rid="MOESM1" ref-type="media">4</xref> for matching factors and control eligibility). One study—Quebec COVID-19 Biobank (“BQC19”)—collected clinical data and biospecimens from 12 hospitals in Quebec [<xref ref-type="bibr" rid="CR38">38</xref>]. The remaining studies are case-cohorts with patients that either have a confirmed or suspected diagnosis of COVID-19. From these studies, the HostSeq Databank includes data from study subjects on demographics, comorbidities and assessment and treatment provided for COVID-19.</p>
      <p id="Par11">Clinical data from the participating studies is systematically harmonized by the HostSeq team in an ongoing process. In the first stage, we verify the raw data by checking for missingness, consistency, inadmissible values, and aberrant values across the variables. In the second stage, we harmonize the data guided by a set of common definitions and rules, including application of uniform classification, coding, and measurement units specified in the HostSeq Codebook (available through the <italic>HostSeq Phenotype Portal</italic> described below in <italic>HostSeq Data Portals</italic>). For example, all laboratory test variables are converted into predefined units; text entries in French are translated into English; and medications and complications variables are coded by timeline (prior to illness vs. during illness vs. post-discharge follow-up). Any potential data errors detected in the harmonization process are communicated to the participating study teams and resolved through follow-up.</p>
      <p id="Par12">Study-specific sample sizes currently range from 11 to 4,602. To date, in the HostSeq databank the 13 studies have contributed 9,913 clinical records and submitted 10,978 samples (Table <xref rid="Tab1" ref-type="table">1</xref>). With the exception of two studies that have recruitment across multiple provinces (CANCOV, CONCOR-Donor; <italic>n</italic> = 2,196), most studies are province-specific: six studies in Ontario (GENCOV, GenOMICC, SCB, LEFT-GEN, genMARK, Understanding Immunity to Coronaviruses; <italic>n</italic> = 3,114), one in Quebec (BQC19; <italic>n</italic> = 4,602), two in Alberta (AB3C; AB-HGS <italic>n</italic> = 262) and two in British Columbia (GD-COVID, Host Factors; <italic>n</italic> = 804). Table S<xref rid="MOESM1" ref-type="media">4</xref> summarizes their research objectives and study designs. Detailed information for each study is also provided on the CGEn website (<ext-link ext-link-type="uri" xlink:href="https://www.cgen.ca/hostseq-studies-2">https://www.cgen.ca/hostseq-studies-2</ext-link>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Status of DNA sample sequencing (as of December 20, 2022)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">STUDY TITLE</th><th align="left">STUDY<break/>ACRONYM</th><th align="left">SAMPLES</th><th align="left">DATA</th></tr></thead><tbody><tr><td align="left">The Hospital for Sick Children’s COVID-19 Biobank</td><td align="left">SCB</td><td align="left">566</td><td align="left">223</td></tr><tr><td align="left">Genetic Markers of Susceptibility to COVID-19</td><td align="left">genMARK</td><td align="left">876</td><td align="left">738</td></tr><tr><td align="left">The Canadian COVID-19 Prospective Cohort Study</td><td align="left">CANCOV</td><td align="left">1409</td><td align="left">1,284</td></tr><tr><td align="left">The Genetics of Mortality in Critical Care</td><td align="left">GenOMICC</td><td align="left">328</td><td align="left">331</td></tr><tr><td align="left">Implementation of Serological and Molecular Tools to Inform COVID-19 Patient Management</td><td align="left">GENCOV</td><td align="left">1,290</td><td align="left">1,111</td></tr><tr><td align="left">Convalescent Plasma for COVID-19 Research</td><td align="left">CONCOR-Donor</td><td align="left">787</td><td align="left">787</td></tr><tr><td align="left">Host Genetic Factors Underlying Severe COVID-19</td><td align="left">Host Factors</td><td align="left">11</td><td align="left">11</td></tr><tr><td align="left">The Quebec COVID-19 Biobank</td><td align="left">BQC-19</td><td align="left">4,602</td><td align="left">4,323</td></tr><tr><td align="left"><p>Genomic Determinants of COVID-19:</p><p>Integration of Host and Viral Genomic Data to Understand the COVID-19 Epidemiologic Triangle</p></td><td align="left">GD-COVID</td><td align="left">793</td><td align="left">793</td></tr><tr><td align="left">HostSeq—Canadian COVID-19 Human Host Genome Sequencing Ottawa</td><td align="left">LEFT-GEN</td><td align="left">43</td><td align="left">43</td></tr><tr><td align="left">Understanding Immunity to Coronaviruses to Develop New Vaccines and Therapies against 2019-nCoV</td><td align="left"/><td align="left">11</td><td align="left">10</td></tr><tr><td align="left">Alberta Childhood COVID-19 Cohort Study</td><td align="left">AB3C</td><td align="left">188</td><td align="left">188</td></tr><tr><td align="left">Host Genetic Susceptibility to Severe Disease from COVID-19 Infection</td><td align="left">AB-HGS</td><td align="left">74</td><td align="left">71</td></tr><tr><td align="left"><bold>TOTAL</bold></td><td align="left"/><td align="left"><bold>10,978</bold></td><td align="left"><bold>9,913</bold></td></tr></tbody></table><table-wrap-foot><p>SAMPLES column indicates DNA samples submitted to HostSeq for sequencing. DATA column indicates raw clinical records submitted to HostSeq. Of these, a total of 9,427 records have been harmonized</p></table-wrap-foot></table-wrap></p>
    </sec>
  </sec>
  <sec id="Sec6">
    <title>Results</title>
    <sec id="Sec7">
      <title>Clinical data summary</title>
      <p id="Par13">The results discussed in this section are based on approximately 95% of the total expected cohort size of 10,000 participants. Although completeness varies across studies, we have achieved over 70% completeness of key variables capturing demographics, comorbidities, healthcare use, and patient outcome. Among the 9,427 currently available harmonized samples, HostSeq has 54.6% females and 41.5% males (and the remaining 3.9% are missing reported sex-at-birth), with an overall mean age (at recruitment) of 47.9 years. Distributions of sex and age vary across the studies (Table S<xref rid="MOESM1" ref-type="media">5</xref>). Apart from studies including pediatric participants (AB3C, SCB), mean age in the studies ranges from 36.9 years (genMARK) to 63.5 years (GenOMICC). Underlying health conditions are collected in all studies, but using a variety of collection methods (medical chart reviews, participant surveys, and patient interviews). A total of 24 comorbidity variables across cardiovascular, respiratory, immunological, neurological systems, and other pathologies are collected in HostSeq. Distributions of comorbidities across the studies are available through the <italic>HostSeq Phenotype Portal</italic>.</p>
      <p id="Par14">While approximately half of the HostSeq participants were hospitalized and half were assessed in outpatient or community settings, the proportion of hospitalized versus non-hospitalized patients varied substantially across the studies. In all but one study (GenOMICC), participants presented predominantly with mild or moderate symptoms and did not require admission to intensive care units or invasive ventilation support. Of the hospitalized patients, 54.0% were discharged home, 15.0% were transferred to other hospitals or healthcare settings (e.g., rehabilitation centers or long-term care facilities) and 11.9% were reported deceased (Table <xref rid="Tab2" ref-type="table">2</xref>).<table-wrap id="Tab2"><label>Table 2</label><caption><p>Hospitalization and patient outcomes in HostSeq</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="3">HostSeq All Studies (<italic>n</italic> = 9,427)<sup>a</sup>
</th></tr></thead><tbody><tr><td align="left" rowspan="2">Age<sup>b</sup>
</td><td align="left">Mean (SD)</td><td align="left">47.9 (29.1)</td></tr><tr><td align="left">Median (min, Q1, Q3, max)</td><td align="left">48.0 (0.1, 33.4, 61.9, 104.2)</td></tr><tr><td align="left" rowspan="2">Sex at birth<sup>c</sup>
</td><td align="left">Male</td><td align="left">3,911 (41.5%)</td></tr><tr><td align="left">Female</td><td align="left">5,144 (54.6%)</td></tr><tr><td align="left" rowspan="2">Hospitalization<sup>d</sup>
</td><td align="left">Yes</td><td align="left">3,478 (36.9%)</td></tr><tr><td align="left">No</td><td align="left">5,354 (56.8%)</td></tr><tr><td align="left" rowspan="2">ICU admission<sup>e</sup>
</td><td align="left">Yes</td><td align="left">1,148 (12.2%)</td></tr><tr><td align="left">No</td><td align="left">6,558 (69.6%)</td></tr><tr><td align="left" rowspan="5">Patient outcome<sup>f,g</sup>
</td><td align="left">Discharged alive</td><td align="left">1,879 (54.0%)</td></tr><tr><td align="left">Transfer to another facility</td><td align="left">521 (15.0%)</td></tr><tr><td align="left">Palliative discharge</td><td align="left">3 (0.1%)</td></tr><tr><td align="left">Hospitalized</td><td align="left">9 (0.3%)</td></tr><tr><td align="left">Death</td><td align="left">414 (11.9%)</td></tr></tbody></table><table-wrap-foot><p><italic>SD</italic> Standard deviation; <sup>a</sup>
<italic>n</italic> = 9,427 is a subset of the expected cohort of greater than 10,000; <sup>b</sup> Data not available for 605 participants (6.4%); <sup>c</sup> Data not available for 372 participants (3.9%); <sup>d</sup> Data not available for 595 participants (6.3%); <sup>e</sup> Data not available for 1,721 participants (18.3%); <sup>f</sup> Denominator is 3,478 hospitalized participants; <sup>g</sup> Data currently in collection for 652 participants (18.7%)</p></table-wrap-foot></table-wrap></p>
    </sec>
    <sec id="Sec8">
      <title>HostSeq data portals</title>
      <p id="Par15">HostSeq provides public access to two data portals: (1) The <italic>Phenotype Portal</italic> shows summaries for the major variables of the HostSeq harmonized clinical data; and (2) the <italic>Variant Search Portal</italic> enables queries in a genomic region to see all variants and their alleles identified in the HostSeq genomes. Both portals are static platforms that are updated periodically when a new release version of their respective data is available.</p>
      <p id="Par16">The <italic>HostSeq Phenotype Portal</italic> (<ext-link ext-link-type="uri" xlink:href="https://hostseq.ca/phenotypes.html">https://hostseq.ca/phenotypes.html</ext-link>) provides information for clinical variables at aggregate and study-specific levels. Users can access variables by category (e.g., demographics, comorbidities, complications) and view their distributions (categorical variables are presented as boxplots, and numerical variables are presented as histograms and violin plots). Displays are limited to variables with ≥ 70% completeness. Researchers can also find links to the HostSeq study protocol and up-to-date data dictionaries on this portal.</p>
      <p id="Par17">The <italic>HostSeq Variant Search Portal</italic> (<ext-link ext-link-type="uri" xlink:href="https://hostseq.ca/dashboard/variants-search">https://hostseq.ca/dashboard/variants-search</ext-link>) allows for queries of the HostSeq genetic data. The primary querying functionality is supported by the CanDIG-server [<xref ref-type="bibr" rid="CR39">39</xref>], a platform enabling federated querying of genomics data. Beacon APIs [<xref ref-type="bibr" rid="CR40">40</xref>] from the Global Alliance for Genomics and Health (GA4GH) are also built-in to allow HostSeq to join the federated Beacon network. Users can query information about a specific allele of interest. Information about the variants that can be queried includes their position and alleles and the respective internal frequencies of the alleles (minor allele frequencies are reported if they exceed 0.1). All columns in the table can be sorted and filtered.</p>
    </sec>
    <sec id="Sec9">
      <title>Genetic data summary</title>
      <p id="Par18">Results reported in this section are based on an interim joint-called set of 6,500 HostSeq genomes, of which 6,316 passed all quality checks (see <italic>Methods</italic>). Our predicted population structure covers five major ancestry groups (Figs. <xref rid="Fig2" ref-type="fig">2</xref> and S<xref rid="MOESM1" ref-type="media">2</xref>, S<xref rid="MOESM1" ref-type="media">3</xref>; 69% European, 6% Admixed American, 8% East Asian, 8% South Asian, 6% African, and approximately 3% uncategorized) and closely matches self-reported ancestries (where available). Additionally, there are 300 and 518 pairs of first- and second-degree relationships, respectively.<fig id="Fig2"><label>Fig. 2</label><caption><p>PCA projection of HostSeq genomes against reference superpopulations. HostSeq genomes were merged with the 1000 Genomes reference set. The first two principal components of this merged data are shown here with HostSeq genomes in black and 1000 Genomes samples colored by their superpopulation: AFR = African, AMR = Admixed American, EAS = East Asian, SAS = South Asian, EUR = European</p></caption><graphic xlink:href="12863_2023_1128_Fig2_HTML" id="MO2"/></fig></p>
      <p id="Par19">Currently HostSeq provides 174.5 million short variants consisting of single nucleotide variants and indels. We report HLA Class I haplotypes for three loci (<italic>HLA-A</italic>, <italic>HLA-B</italic> and <italic>HLA-C</italic>) with bi-allelic typing at 4-digit resolution (allele group with specific alleles). The numbers of unique alleles for <italic>HLA-A</italic>, <italic>HLA-B</italic> and <italic>HLA-C</italic> in 4436 genomes are 73, 145 and 49, respectively (the most common alleles per locus are <italic>HLA-A*</italic>02:01, <italic>HLA-B*</italic>07:02 and <italic>HLA-C*</italic>07:01).</p>
    </sec>
  </sec>
  <sec id="Sec10">
    <title>Utility and discussion</title>
    <p id="Par20">HostSeq provides unique opportunities to explore the genetics among SARS-CoV-2 positive individuals in Canada and the facilitation of an organizational governance and oversight for researchers in Canada and beyond. Even though the participating studies in HostSeq are heterogenous with different designs and objectives (Table <xref rid="Tab3" ref-type="table">3</xref> and Table S<xref rid="MOESM1" ref-type="media">4</xref>), HostSeq is an opportunity to leverage that diversity to address research questions. Several issues need to be considered when analysing HostSeq data in a given research context. For example: (1) whether data from different studies should be analysed separately or combined (and how to combine those data); (2) the selection strategies used by the contributing studies to recruit participants; (3) adjustment of covariates for association tests with genetic variants; and (4) the details of X chromosome analysis.<table-wrap id="Tab3"><label>Table 3</label><caption><p>Aspects of participant ascertainment in HostSeq</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Desired research study eligibility</th><th align="left">Active infection at recruitment</th><th align="left">Past infection or disease at recruitment</th></tr></thead><tbody><tr><td align="left">Infected participants in ICU</td><td align="left"><p>Host Factors</p><p>BQC19</p><p>CANCOV</p><p>GENCOV</p><p>GenOMICC</p><p>SCB</p></td><td align="left"><p>SCB</p><p>AB-HGS</p></td></tr><tr><td align="left"><p>Infected inpatient participants</p><p>(i.e., hospitalized)</p></td><td align="left"><p>AB3C</p><p>Host Factors</p><p>BQC19</p><p>CANCOV</p><p>GENCOV</p><p>SCB</p></td><td align="left"><p>AB-HGS</p><p>GENCOV</p><p>genMARK</p><p>LEFT-GEN</p><p>SCB</p></td></tr><tr><td align="left">Infected outpatient participants</td><td align="left"><p>AB3C</p><p>BQC19</p><p>CANCOV</p><p>GENCOV</p><p>genMARK</p></td><td align="left"><p>genMARK</p><p>GD-COVID-19</p><p>GENCOV</p><p>LEFT-GEN</p><p>SCB</p></td></tr><tr><td align="left">Infected participants from community enrollment</td><td align="left"/><td align="left">CONCOR-Donor</td></tr></tbody></table><table-wrap-foot><p>Study participants who were not confirmed to be positive for infection either by molecular/serology test or clinical symptoms are not included in this Table</p></table-wrap-foot></table-wrap></p>
    <sec id="Sec11">
      <title>Individual or combined analysis</title>
      <p id="Par21">Whether an investigator’s research question would be best answered by within-study comparisons or analyses including multiple studies will require careful consideration of participant ascertainment criteria. For example, comorbidities might be analyzed within-study then combined via a meta-analysis to account for differences in study designs among the contributing studies. In contrast, for the disease severity indicated by hospitalization duration, it may be appropriate to jointly analyze the subset of studies that focus on in-patient recruitment. Table <xref rid="Tab3" ref-type="table">3</xref> provides details for the recruitment aspects that may frame such research questions. For example, to compare the genetics of hospitalized patients to non-hospitalized patients within the same study, data from AB3C, BQC19, CANCOV, GENCOV, genMARK, LEFT-GEN and SCB could be used. To compare ICU patients to non-ICU hospitalized patients, Host Factors, BQC19, CANCOV, GENCOV and SCB could be used.</p>
      <p id="Par22">Given the heterogeneity of the studies in HostSeq, the best approach for certain outcomes may be to analyse relevant studies individually. The feasibility of combining estimates or test results from separate studies, as in meta-analyses, depends on whether the individual studies measure and estimate the same features. The appropriateness of a joint analysis of participant data from multiple studies in an overarching model (perhaps with inclusion of study effects) also depends on whether the studies measure those same features. Although the combination of study-level estimates or tests can be as efficient as joint analysis in large samples [<xref ref-type="bibr" rid="CR41">41</xref>], meta-analysis of summary data can be less efficient in smaller samples. When individual data are available, joint analysis is recommended, incorporating sparse-data methods for variants with low minor allele counts and outcomes with low prevalence [<xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR43">43</xref>]. Furthermore, with study or environmental factors and other sources of heterogeneity, joint analysis can exploit gene-environment interaction [<xref ref-type="bibr" rid="CR44">44</xref>] and give insight into sources of within- and between-study variation.</p>
      <p id="Par23">Given the dynamic nature of the COVID-19 pandemic, temporal and spatial variation within- and between-studies is another source of heterogeneity that is challenging and deserves consideration. Studies with prolonged recruitment and wide variation in dates of infection may allow such factors to be examined. When looking across the participating HostSeq studies, it may be of interest to examine changes in the profiles of recruited patients as the seropositivity rates and vaccination rates changed with time across Canada and as treatments changed and improved (for example, by combining HostSeq data with serological studies).</p>
    </sec>
    <sec id="Sec12">
      <title>Participant selection mechanism</title>
      <p id="Par24">Most of the participating studies are designed to include individuals who tested positive for SARS-CoV-2 at a participating institution or individuals who volunteered to donate blood and previously had a positive test. For such participants, it can be difficult to specify exactly what population they represent. To reduce bias and improve interpretation of results, the processes by which individuals join a given study needs to be considered [<xref ref-type="bibr" rid="CR45">45</xref>]. Here, we interpret bias relative to the effect of a variable (genetic or otherwise) in a target population. If an analysis is to involve an outcome variable (e.g., hospitalized versus not hospitalized), a genetic variable of interest and some additional covariates, then the validity of standard statistical methods is linked to how the sample inclusion depends on the outcome. Such dependence occurs in response-selective designs in which individuals are included in a study according to the values of an outcome [<xref ref-type="bibr" rid="CR46">46</xref>–<xref ref-type="bibr" rid="CR48">48</xref>]. Except for the simple case–control setting, weighting or conditional estimation is needed to avoid estimation bias of the genetic association. Such methods require estimation or specification of the probability of being selected for inclusion. We encourage analyses that address study sample selection mechanisms.</p>
      <p id="Par25">Methods to account explicitly for selection conditions are similar to methods used for the analysis of secondary traits in case–control studies [<xref ref-type="bibr" rid="CR49">49</xref>, <xref ref-type="bibr" rid="CR50">50</xref>]. From a methodological standpoint, we also encourage studies of bias and Type 1 error control when standard analyses are used (such as unweighted logistic regression). When the selection mechanism is not easily described, comparison of study samples to population or administrative data may provide insights.</p>
      <p id="Par26">Finally, as HostSeq includes various ancestries, care must be taken to avoid confounding through population stratification (for example, by use of stratification, mixed models, and genetic principal components). This issue, alongside issues related to the heterogeneity of participating studies, are not unique to HostSeq, and arise in most collaborative multi-center or consortium-based research.</p>
    </sec>
    <sec id="Sec13">
      <title>Covariate adjustment</title>
      <p id="Par27">The choice of adjustment covariates in tests for association of outcome with a genetic variant is context dependent and open to discussion in many settings [<xref ref-type="bibr" rid="CR51">51</xref>, <xref ref-type="bibr" rid="CR52">52</xref>]. In testing for genetic associations with COVID-19 outcomes, one strategy would be to adjust for factors such as age and sex that may affect selection or the outcome in question but are not associated with the genetic variant (unless it is on the sex chromosomes; as mentioned below in <italic>Sex difference and X Chromosome Analyses</italic> below). We must also consider whether to adjust for factors such as comorbidities, which may be related both to the outcome and to the variant. This is of particular importance for severe COVID-19: in the ICU, 1-year mortality outcomes increase with each additional week spent in ICU, each decade in age, and each additional comorbid illness in the Charlson score [<xref ref-type="bibr" rid="CR53">53</xref>]. From a causal perspective, adjusting for multiple covariates without a clear conceptual framework could lead to adjustment for variables that lie on the causal pathway [<xref ref-type="bibr" rid="CR54">54</xref>]. If there is a causal link from variant to outcome that passes through such a variable, then researchers could choose to test for either direct or indirect effects of the variant. As part of the process of learning about genetic effects on COVID-19 outcomes, we encourage analyses both with and without adjusting for such factors.</p>
      <p id="Par28">For the discovery stage in genetic association studies, power considerations are important. There have been suggestions that adjusting for too many covariates decreases power [<xref ref-type="bibr" rid="CR52">52</xref>, <xref ref-type="bibr" rid="CR55">55</xref>], and that two-phase strategies of genome-wide screening by simple analysis followed by targeted in-depth modelling is adequate and efficient. However, this is an area for which further study is warranted.</p>
    </sec>
    <sec id="Sec14">
      <title>Sex difference and X chromosome analyses</title>
      <p id="Par29">COVID-19 displays sexual dimorphism with greater severity in males [<xref ref-type="bibr" rid="CR56">56</xref>–<xref ref-type="bibr" rid="CR58">58</xref>]. In addition to environmental exposures and sex-specific autosomal genetic effects, it is reasonable to hypothesize that some X chromosomal variants play a role in COVID-19 outcomes. Indeed, one gene on the X-chromosome, the angiotensin-converting enzyme 2 (<italic>ACE2</italic>, Xp22.2), has been reported to be important in SARS-Cov-2 infection and genetic analysis has demonstrated association evidence with <italic>ACE2</italic> variants [<xref ref-type="bibr" rid="CR19">19</xref>].</p>
      <p id="Par30">However, all published GWAS of SARS-CoV-2 susceptibility or COVID-19 severity, to the best of our knowledge, uses the traditional genotype coding (0, 1 and 2 for a female; 0 and 2 for a male) that assumes X-inactivation through a dosage compensation model (i.e., with alleles in the non-pseudo-autosomal regions being expressed exactly half of the time in genetic females [<xref ref-type="bibr" rid="CR59">59</xref>]). Yet, it has been reported that close to one-third of the X chromosome genes can escape X-inactivation [<xref ref-type="bibr" rid="CR60">60</xref>, <xref ref-type="bibr" rid="CR61">61</xref>]; if so, the genotype of a male should be coded 0 and 1 by convention. To robustly deal with X-inactivation uncertainty we recommend the use of recent methods for genetic analysis of SARS-CoV-2 related research questions such as model averaging and selection [<xref ref-type="bibr" rid="CR62">62</xref>, <xref ref-type="bibr" rid="CR63">63</xref>] and an easy-to-implement regression model [<xref ref-type="bibr" rid="CR64">64</xref>]. Rare X-chromosome variant analysis [<xref ref-type="bibr" rid="CR65">65</xref>, <xref ref-type="bibr" rid="CR66">66</xref>] and X-inclusive polygenic risk scores also require careful consideration and further research.</p>
    </sec>
    <sec id="Sec15">
      <title>Health research in the Canadian context</title>
      <p id="Par31">People living in Canada are insured under single-payer health care systems administered at the provincial or territorial level. These systems broadly cover physician and hospital services, as well as procedures. This provides a unique opportunity to conduct passive follow-up to understand the short-term and long-term outcomes related to SARS-CoV-2 infection. Administrative health data are generated through patient contact with the health care systems and maintained in multiple databases that, with the appropriate approvals, can be linked using a unique encoded identifier to study specific, patient-level data (including genetic data). These data are administrative or procedural (e.g., surgeries, emergency department visits, hospital visits, comorbidities, routine medical exams), clinical (e.g., prescription medications, cancer screening), laboratory (e.g., blood measurements), social (e.g., education, income), and environmental (e.g., rurality, walkability, food insecurity, exposure to air pollution). The participant informed consent used by HostSeq allows for linkage to these data, transforming the HostSeq dataset into a longitudinal study. Specifically, linkage to administrative provincial data will provide: 1) a retrospective, longitudinal account of medical histories, health system utilization and diagnoses; and 2) prospective, longitudinal follow-up tracking the natural history of SARS-CoV-2 infection including multisystem inflammatory syndrome in children (MIS-C) and Long COVID, identifying new diagnoses (e.g., diabetes, cancer), long-term health outcomes (e.g., premature mortality), and health resource utilization. Linkage of the HostSeq study samples to provincial administrative data offers opportunities to collect additional data on risk factors and longitudinal outcomes, and opportunities to extend genetic association analyses. Administrative data can also facilitate evaluation of the representativeness of study samples and inform future study design.</p>
      <p id="Par32">The limitations of HostSeq data for investigation of specific scientific questions depend on limitations of the relevant participant studies. In addition, investigations that involve combining data or results from separate participant studies may require assumptions about comparability or heterogeneity; such assumptions should be scrutinized.</p>
    </sec>
  </sec>
  <sec id="Sec16">
    <title>Conclusions</title>
    <p id="Par33">Through the HostSeq initiative, Canada has built research infrastructure to investigate health effects of SARS-CoV-2 infection and COVID-19, and their association with genetic variants. This infrastructure can also be used for future epidemics. The unique features of the HostSeq project highlighted here present novel opportunities to develop, evaluate, and apply statistical methods that contribute to the understanding of genetic associations with COVID-19-related morbidity and mortality, as well as other phenotypes. The augmentation and linkage of the HostSeq questionnaire and genetic databank with other data resources is made possible by broad and flexible consent and will generate a dynamic population-based resource. This will allow for study of a broad range of research questions and sustained productivity over the years to come.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Information</title>
    <sec id="Sec17">
      <p>
        <supplementary-material content-type="local-data" id="MOESM1">
          <media xlink:href="12863_2023_1128_MOESM1_ESM.docx">
            <caption>
              <p><bold>Additional file 1: Table S1.</bold> HostSeq Core Consent Elements. In order to deposit datasets in HostSeq COVID-19 controlled-access Databank, all the elements in this table must be obtained in the research consent. <bold>Table S2.</bold> HostSeq Case Report Form. <bold>Table S3.</bold> Software used for processing WGS data. <bold>Table S4.</bold> List of HostSeq participating studies as described in respective protocols. <bold>Table S5.</bold> Distribution of sex and age across HostSeq studies (<italic>n</italic> = 9,427). SD: Standard deviation; IQR: interquartile range. <bold>Figure S1.</bold> Quality of HostSeq genomes. (A) Missing rate &lt; 5%, (B) Contamination rate &lt; 3%, (C) Mean coverage &gt;10. <bold>Figure S2.</bold> Predicted population admixture and ancestry classification in HostSeq genomes. Each bar represents a genome. Proportion of African, East Asian and European ancestries is determined, and genomes classified into 8 ancestry groups using GRAF-pop. They are further categorized into 5 superpopulations: AFR - African and African-American, AMR - Latin American Asian and Latin American African, EAS - Asian-Pacific Islander and East Asian, SAS - South Asian, and EUR - European. 3% of genomes remain uncategorized. <bold>Figure S3.</bold> Genetic distances score of HostSeq genomes. The four genetic distances (GD1-4) scores from GRAF-pop represent the distance of each genome from several reference populations and are used to predict ancestry. Barycentric coordinates of GD1 and GD2 are used to predict admixture proportion of African, East Asian and European ancestries.</p>
            </caption>
          </media>
        </supplementary-material>
      </p>
    </sec>
  </sec>
</body>
<back>
  <fn-group>
    <fn id="Fn1">
      <label>1</label>
      <p id="Par40">
        <ext-link ext-link-type="uri" xlink:href="https://ftp.1000genomes.ebi.ac.uk/vol1/ftp/technical/reference/GRCh38_reference_genome/">https://ftp.1000genomes.ebi.ac.uk/vol1/ftp/technical/reference/GRCh38_reference_genome/</ext-link>
      </p>
    </fn>
    <fn>
      <p>
        <bold>Publisher’s Note</bold>
      </p>
      <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
    </fn>
    <fn>
      <p>S Yoo and E Garg contributed equally.</p>
    </fn>
  </fn-group>
  <ack>
    <title>Acknowledgements</title>
    <p>We wish to express gratitude to all HostSeq project participant studies and the individual participants within these studies for their contribution.</p>
  </ack>
  <notes notes-type="author-contribution">
    <title>Authors’ contributions</title>
    <p>LJS led the study design and implementation. Data harmonization: SY; genomic data analysis: EG. Genetic epidemiology: LJS, JDB, SBB, LTE, FG, CMTG, RJH, JFL, ADP, LS. Writing: SY, EG, LTE, RJH, ARH, JDB, SBB, FG, CMTG, JFL, ADP, LS, LJS. Data processing and sharing: SY, EG, LTE, MLo, ARH, RJSA, IB, GB, J-MG, CG, JL, JW, BT, MSR, J-AH, OOA, SL, MHZ; SJMJ led the data processing and sharing. Study contributors: JL-E, UA, FPB, CMB, AMC, JC, MH, DMM, BPM, VM, SKM, MO, RSP, GP, OS, JT, SET, JU, RLW, RSMY. NA coordinated the three CGEn nodes; SET led study site recruitment; BMK designed the consent and data access process; MLa led the Quebec site; SJ led sequence informatics and the variant portal; NA, SWS and LJS provided overall study oversight. The author(s) read and approved the final manuscript.
</p>
  </notes>
  <notes notes-type="funding-information">
    <title>Funding</title>
    <p>
      <table-wrap id="Taba">
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th align="left">PI, Affiliations</th>
              <th align="left">Study name</th>
              <th align="left">Grants (funder and details)</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left">Stephen Scherer, Lisa Strug, The Hospital for Sick Children, Toronto, ON</td>
              <td align="left">
                <bold>CGEn HostSeq—Canadian COVID-19 Human Host Genome Sequencing Databank</bold>
              </td>
              <td align="left">Genome Canada, Innovation, Science and Economic Development Canada</td>
            </tr>
            <tr>
              <td align="left">Vincent Mooser, CGEn-Montreal, QC</td>
              <td align="left">
                <bold>Biobanque Quebec COVID-19</bold>
              </td>
              <td align="left">
                <p>PHAC 2021-HQ-000051</p>
                <p>FRQ-S</p>
                <p>MSSS</p>
              </td>
            </tr>
            <tr>
              <td align="left">Rae Yeung, The Hospital for Sick Children, Toronto, ON</td>
              <td align="left">
                <bold>SickKids COVID-19 Biobank</bold>
              </td>
              <td align="left">
                <p>CFI cost center # 6,220,200,122 (Proposal ID HSC0005268)</p>
                <p>CIHR/COVID-19 Immunity Task Force:</p>
                <p>CIHR GA4-177,739</p>
                <p>CIHR MM1-181,123</p>
              </td>
            </tr>
            <tr>
              <td align="left">Angela Cheung and Margaret Herridge, University Health Network, Toronto, ON</td>
              <td align="left">
                <bold>The Canadian COVID-19 Prospective Cohort Study (CanCOV)</bold>
              </td>
              <td align="left">
                <p>Canadian Institutes of Health Research (CIHR), COVID-19 Rapid Research Funding Opportunity—Clinical Management and Health System</p>
                <p>CIHR/COVID-19 Immunity Task Force:</p>
                <p>Grant number: 447643</p>
              </td>
            </tr>
            <tr>
              <td align="left">Jordan Lerner-Ellis, Jennifer Taher, Sinai Health, Toronto, ON</td>
              <td align="left">
                <bold>Implementation of serological and molecular tools to inform COVID-19 patient management (GENCOV)</bold>
              </td>
              <td align="left">
                <p>CIHR #VR4-172,753</p>
                <p>CIHR sub-awards: # 461,170 and #461,304</p>
              </td>
            </tr>
            <tr>
              <td align="left">Rulan Parekh, The Hospital for Sick Children, Toronto, ON</td>
              <td align="left">
                <bold>Adaptive Immunity and Outcomes of Convalescent Plasma</bold>
              </td>
              <td align="left">Ministry of Colleges and Universities (Ontario COVID-19 Rapid Research Fund)</td>
            </tr>
            <tr>
              <td align="left">Francois Bernier, University of Calgary, Calgary, AB</td>
              <td align="left">
                <bold>Alberta Childhood COVID-19 Cohort (ABCCC)</bold>
              </td>
              <td align="left">
                <p>Genome Alberta (RRP2)</p>
                <p>Alberta Children’s Hospital</p>
                <p>Mitogen DX</p>
              </td>
            </tr>
            <tr>
              <td align="left">Upton Allen, The Hospital for Sick Children, Toronto, ON</td>
              <td align="left">
                <bold>COVID-19 genMARK study</bold>
              </td>
              <td align="left">
                <p>SickKids Foundation</p>
                <p>University of Toronto # 508,791</p>
              </td>
            </tr>
            <tr>
              <td align="left">Stuart Turvey, BC Children’s Hospital, Vancouver, BC</td>
              <td align="left">
                <bold>Genomic determinants of COVID-19</bold>
              </td>
              <td align="left">Genome British Columbia COV199</td>
            </tr>
            <tr>
              <td align="left">David Maslove, Queens University, Kingston, ON</td>
              <td align="left">
                <bold>Genetics of Mortality in critical care (GenOMICC)</bold>
              </td>
              <td align="left">Ontario Innovation Fund Innovation Grant administered by the Southeastern Ontario Academic Medical Organization (SEAMO)</td>
            </tr>
            <tr>
              <td align="left">Catherine Biggs, Stuart Turvey, BC Children’s Hospital, Vancouver, BC</td>
              <td align="left">
                <bold>Improving outcomes through precision medicine for adults with primary immunodeficiencies</bold>
              </td>
              <td align="left">Providence Healthcare Research Institute</td>
            </tr>
            <tr>
              <td align="left">Mario Ostrowski, St. Michael’s Hospital, Unity Health, Toronto, ON</td>
              <td align="left">
                <bold>Understanding Immunity to Coronaviruses to Develop New Vaccines and Therapies against 2019-nCoV</bold>
              </td>
              <td align="left">CIHR VR1-172,711</td>
            </tr>
            <tr>
              <td align="left">Gerald Pfeffer, University of Calgary, Calgary, AB</td>
              <td align="left">
                <bold>Host Genetic Susceptibility to Severe Disease from COVID-19 Infection</bold>
              </td>
              <td align="left">
                <p>Hotchkiss Brain Institute, University of Calgary</p>
                <p>Cumming School of Medicine, University of Calgary</p>
              </td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
    </p>
  </notes>
  <notes notes-type="data-availability">
    <title>Availability of data and materials</title>
    <p>The datasets generated and analysed during the current study are made available to researchers worldwide through a Data Access Agreement and Data Access Compliance Office (DACO) approval (<ext-link ext-link-type="uri" xlink:href="https://www.cgen.ca/daco-main">https://www.cgen.ca/daco-main</ext-link>). The datasets are deposited in the HostSeq Databank, which is a data repository that facilitates data access controls that are suitable for hosting sensitive health data. Access to this repository is granted to any researcher with DACO approval. The DACO verifies that the proposed research has REB approval from their host institution and conforms to HostSeq’s REB-approved SARS-CoV-2 or other health outcome research. DACO-approved researchers sign inter-institutional legal agreements, which outline how the shared data is to be used, stored, and privacy protected.</p>
    <p>Aggregated data are publicly available through two data portals: a phenotype portal showing summaries of major variables (<ext-link ext-link-type="uri" xlink:href="https://hostseq.ca/phenotypes.html">https://hostseq.ca/phenotypes.html</ext-link>) and their distributions, and a variant search portal enabling queries in a genomic region (<ext-link ext-link-type="uri" xlink:href="https://hostseq.ca/dashboard/variants-search">https://hostseq.ca/dashboard/variants-search</ext-link>). Access to the variant search portal requires a login (any researcher can register for a login to the variant search portal).</p>
    <p>The code used for processing the WGS data can be found in a publicly accessible repository: <ext-link ext-link-type="uri" xlink:href="https://svn.bcgsc.ca/bitbucket/users/jmgarant">https://svn.bcgsc.ca/bitbucket/users/jmgarant</ext-link>.</p>
  </notes>
  <notes>
    <title>Declarations</title>
    <notes id="FPar1">
      <title>Ethics approval and consent to participate</title>
      <p id="Par34">HostSeq was approved by the Research Ethics Board of the Hospital for Sick Children (lead site) (#1000070720 from 2020-present). Written informed consent was obtained from all participants or parents/guardians/substitute decision makers prior to inclusion in the study.</p>
      <p id="Par35">Additional REB information from the participating PIs:</p>
      <p id="Par36">
        <table-wrap id="Tabb">
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th align="left">Site</th>
                <th align="left">PI</th>
                <th align="left">REB</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left">The Hospital for Sick Children</td>
                <td align="left">Stephen Scherer</td>
                <td align="left">1000070720</td>
              </tr>
              <tr>
                <td align="left">The Hospital for Sick Children</td>
                <td align="left">Rae Yeung</td>
                <td align="left">1000070060</td>
              </tr>
              <tr>
                <td align="left">The Hospital for Sick Children</td>
                <td align="left">Upton Allen</td>
                <td align="left">1000069580</td>
              </tr>
              <tr>
                <td align="left">University Health Network</td>
                <td align="left">Angela Cheung</td>
                <td align="left">CTO ID 2157</td>
              </tr>
              <tr>
                <td align="left">Queens University</td>
                <td align="left">David Maslove</td>
                <td align="left">CTO ID 3209</td>
              </tr>
              <tr>
                <td align="left">Mount Sinai Hospital</td>
                <td align="left">Jordan Lerner-Ellis</td>
                <td align="left">CTO ID 3302</td>
              </tr>
              <tr>
                <td align="left">The Hospital for Sick Children</td>
                <td align="left">Rulan Parekh</td>
                <td align="left">1000070462</td>
              </tr>
              <tr>
                <td align="left">BC Children's Hospital</td>
                <td align="left">Catherine Biggs</td>
                <td align="left">H20-01667</td>
              </tr>
              <tr>
                <td align="left">University of Montreal Health Centre</td>
                <td align="left"/>
                <td align="left">19.389 (internal) MP-02–2020-8929 (multicentre)</td>
              </tr>
              <tr>
                <td align="left">BC Children;s Hospital</td>
                <td align="left">Stuart Turvey</td>
                <td align="left">H21-00054</td>
              </tr>
              <tr>
                <td align="left">The Ottawa Hospital</td>
                <td align="left">Juthaporn Cowan</td>
                <td align="left">20210119-01H</td>
              </tr>
              <tr>
                <td align="left">Unity Health</td>
                <td align="left">Mario Ostrowski</td>
                <td align="left">20–044</td>
              </tr>
              <tr>
                <td align="left">University of Calgary</td>
                <td align="left">Gerald Pfeffer</td>
                <td align="left">20-0574_MOD3</td>
              </tr>
              <tr>
                <td align="left">University of Calgary</td>
                <td align="left">Francois Bernier</td>
                <td align="left">20-0480_MOD6</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
      </p>
    </notes>
    <notes id="FPar2">
      <title>Consent for publication</title>
      <p id="Par37">Not applicable.</p>
    </notes>
    <notes id="FPar3" notes-type="COI-statement">
      <title>Competing interests</title>
      <p id="Par38">The authors declare that they have no competing interests.</p>
    </notes>
  </notes>
  <ref-list id="Bib1">
    <title>References
</title>
    <ref id="CR1">
      <label>1.</label>
      <mixed-citation publication-type="other">Government of Canada. COVID-19 signs, symptoms and severity of disease: A clinician guide. 2021 [Accessed Summer 2022]. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection/guidance-documents/signs-symptoms-severity.html">https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection/guidance-documents/signs-symptoms-severity.html</ext-link>.
</mixed-citation>
    </ref>
    <ref id="CR2">
      <label>2.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lin</surname>
            <given-names>YC</given-names>
          </name>
          <name>
            <surname>Brooks</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Bull</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Gagnon</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Greenwood</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Hung</surname>
            <given-names>R</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Statistical power in COVID-19 case-control host genomic study design</article-title>
        <source>Genome Med</source>
        <year>2020</year>
        <volume>12</volume>
        <issue>1</issue>
        <fpage>115</fpage>
        <?supplied-pmid 33371892?>
        <pub-id pub-id-type="pmid">33371892</pub-id>
      </element-citation>
    </ref>
    <ref id="CR3">
      <label>3.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Allers</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Schneider</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>CCR5Δ32 mutation and HIV infection: Basis for curative HIV therapy</article-title>
        <source>Curr Opin Virol</source>
        <year>2015</year>
        <volume>14</volume>
        <fpage>24</fpage>
        <lpage>29</lpage>
        <?supplied-pmid 26143158?>
        <pub-id pub-id-type="pmid">26143158</pub-id>
      </element-citation>
    </ref>
    <ref id="CR4">
      <label>4.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Nordgren</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Svensson</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>Genetic susceptibility to human norovirus infection: An Update</article-title>
        <source>Viruses</source>
        <year>2019</year>
        <volume>11</volume>
        <issue>3</issue>
        <fpage>226</fpage>
        <?supplied-pmid 30845670?>
        <pub-id pub-id-type="pmid">30845670</pub-id>
      </element-citation>
    </ref>
    <ref id="CR5">
      <label>5.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Coppola</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Marrone</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Pisaturo</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Starace</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Signoriello</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Gentile</surname>
            <given-names>I</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection</article-title>
        <source>Eur J Clin Microbiol Infect Dis</source>
        <year>2014</year>
        <volume>33</volume>
        <issue>4</issue>
        <fpage>559</fpage>
        <lpage>567</lpage>
        <?supplied-pmid 24081499?>
        <pub-id pub-id-type="pmid">24081499</pub-id>
      </element-citation>
    </ref>
    <ref id="CR6">
      <label>6.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Trandem</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Anghelina</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Perlman</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Regulatory T cells in hibit T cell proliferation and decrease demyelination in mice chronically infected with a coronavirus</article-title>
        <source>J Immunol</source>
        <year>2010</year>
        <volume>184</volume>
        <issue>8</issue>
        <fpage>4391</fpage>
        <lpage>4400</lpage>
        <?supplied-pmid 20208000?>
        <pub-id pub-id-type="pmid">20208000</pub-id>
      </element-citation>
    </ref>
    <ref id="CR7">
      <label>7.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mahallawi</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Khabour</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Makhdoum</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Suliman</surname>
            <given-names>B</given-names>
          </name>
        </person-group>
        <article-title>MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile</article-title>
        <source>Cytokine</source>
        <year>2018</year>
        <volume>104</volume>
        <fpage>8</fpage>
        <lpage>13</lpage>
        <?supplied-pmid 29414327?>
        <pub-id pub-id-type="pmid">29414327</pub-id>
      </element-citation>
    </ref>
    <ref id="CR8">
      <label>8.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ng</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Lau</surname>
            <given-names>KM</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Cheng</surname>
            <given-names>SH</given-names>
          </name>
          <name>
            <surname>Chan</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Hui</surname>
            <given-names>P</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Association of human-leukocyte-antigen class I (B*0703) and class II (DRB1*0301) genotypes with susceptibility and resistance to the development of severe acute respiratory syndrome</article-title>
        <source>J Infect Dis</source>
        <year>2004</year>
        <volume>190</volume>
        <issue>3</issue>
        <fpage>515</fpage>
        <lpage>518</lpage>
        <?supplied-pmid 15243926?>
        <pub-id pub-id-type="pmid">15243926</pub-id>
      </element-citation>
    </ref>
    <ref id="CR9">
      <label>9.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lin</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Tseng</surname>
            <given-names>HK</given-names>
          </name>
          <name>
            <surname>Trejaut</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>HL</given-names>
          </name>
          <name>
            <surname>Loo</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Chu</surname>
            <given-names>CC</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Association of HLA class I with severe acute respiratory syndrome coronavirus infection</article-title>
        <source>BMC Med Genet</source>
        <year>2003</year>
        <volume>4</volume>
        <issue>1</issue>
        <fpage>1</fpage>
        <lpage>7</lpage>
        <pub-id pub-id-type="pmid">12529183</pub-id>
      </element-citation>
    </ref>
    <ref id="CR10">
      <label>10.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pairo-Castineira</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Clohisey</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Klaric</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Bretherick</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Rawlik</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Pasko</surname>
            <given-names>D</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Genetic mechanisms of critical illness in COVID-19</article-title>
        <source>Nature</source>
        <year>2021</year>
        <volume>591</volume>
        <issue>7848</issue>
        <fpage>92</fpage>
        <lpage>98</lpage>
        <?supplied-pmid 33307546?>
        <pub-id pub-id-type="pmid">33307546</pub-id>
      </element-citation>
    </ref>
    <ref id="CR11">
      <label>11.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kousathanas</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Pairo-Castineira</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Rawlik</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Stuckey</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Odhams</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Walker</surname>
            <given-names>S</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Whole genome sequencing reveals host factors underlying critical COVID-19</article-title>
        <source>Nature</source>
        <year>2022</year>
        <volume>607</volume>
        <issue>7917</issue>
        <fpage>97</fpage>
        <lpage>103</lpage>
        <?supplied-pmid 35255492?>
        <pub-id pub-id-type="pmid">35255492</pub-id>
      </element-citation>
    </ref>
    <ref id="CR12">
      <label>12.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <collab>COVID-19 Host Genetics Initiative</collab>
        </person-group>
        <article-title>Mapping the human genetic architecture of COVID-19</article-title>
        <source>Nature</source>
        <year>2021</year>
        <volume>600</volume>
        <issue>7889</issue>
        <fpage>472</fpage>
        <lpage>7</lpage>
        <pub-id pub-id-type="pmid">34237774</pub-id>
      </element-citation>
    </ref>
    <ref id="CR13">
      <label>13.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Bastard</surname>
            <given-names>P</given-names>
          </name>
          <collab>COVID Human Genetic Effort</collab>
          <name>
            <surname>Cobat</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Casanova</surname>
            <given-names>JL</given-names>
          </name>
        </person-group>
        <article-title>Human genetic and immunological determinants of critical COVID-19 pneumonia</article-title>
        <source>Nature</source>
        <year>2022</year>
        <volume>603</volume>
        <issue>7902</issue>
        <fpage>587</fpage>
        <lpage>98</lpage>
        <?supplied-pmid 35090163?>
        <pub-id pub-id-type="pmid">35090163</pub-id>
      </element-citation>
    </ref>
    <ref id="CR14">
      <label>14.</label>
      <mixed-citation publication-type="other">COVID-19 Host Genetics Initiative. A first update on mapping the human genetic architecture of COVID-19. Nature. 2022;608(7921):E1-E10.</mixed-citation>
    </ref>
    <ref id="CR15">
      <label>15.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Niemi</surname>
            <given-names>MEK</given-names>
          </name>
          <name>
            <surname>Daly</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>Ganna</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>The human genetic epidemiology of COVID-19</article-title>
        <source>Nat Rev Genet</source>
        <year>2022</year>
        <volume>23</volume>
        <issue>5</issue>
        <fpage>533</fpage>
        <lpage>546</lpage>
        <?supplied-pmid 35501396?>
        <pub-id pub-id-type="pmid">35501396</pub-id>
      </element-citation>
    </ref>
    <ref id="CR16">
      <label>16.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Raina</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Wolfson</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Kirkland</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Griffith</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Oremus</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Patterson</surname>
            <given-names>C</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The Canadian Longitudinal Study on Aging (CLSA)</article-title>
        <source>Can J Aging Rev Can Vieil</source>
        <year>2009</year>
        <volume>28</volume>
        <issue>3</issue>
        <fpage>221</fpage>
        <lpage>229</lpage>
      </element-citation>
    </ref>
    <ref id="CR17">
      <label>17.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Dummer</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Awadalla</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Boileau</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Craig</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Fortier</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Goel</surname>
            <given-names>V</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The Canadian partnership for tomorrow project: a pan-Canadian platform for research on chronic disease prevention</article-title>
        <source>Can Med Assoc J</source>
        <year>2018</year>
        <volume>190</volume>
        <issue>23</issue>
        <fpage>E710</fpage>
        <lpage>E717</lpage>
        <pub-id pub-id-type="pmid">29891475</pub-id>
      </element-citation>
    </ref>
    <ref id="CR18">
      <label>18.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Song</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Brinkman</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Gill</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Griffiths</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Hsiao</surname>
            <given-names>W</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Addressing privacy concerns in sharing viral sequences and minimum contextual data in a public repository during the COVID-19 pandemic</article-title>
        <source>Front Genet</source>
        <year>2022</year>
        <volume>12</volume>
        <fpage>716541</fpage>
        <?supplied-pmid 35401651?>
        <pub-id pub-id-type="pmid">35401651</pub-id>
      </element-citation>
    </ref>
    <ref id="CR19">
      <label>19.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <collab>COVID-19 Host Genetics Initiative</collab>
        </person-group>
        <article-title>A first update on mapping the human genetic architecture of COVID-19</article-title>
        <source>Nature</source>
        <year>2022</year>
        <volume>608</volume>
        <issue>7921</issue>
        <fpage>97</fpage>
        <lpage>103</lpage>
      </element-citation>
    </ref>
    <ref id="CR20">
      <label>20.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Knoppers</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Beauvais</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Joly</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Zawati</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Rousseau</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Chasse</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Modeling consent in the time of COVID-19</article-title>
        <source>J Law Biosci</source>
        <year>2020</year>
        <volume>7</volume>
        <issue>1</issue>
        <fpage>1</fpage>
        <lpage>6</lpage>
      </element-citation>
    </ref>
    <ref id="CR21">
      <label>21.</label>
      <mixed-citation publication-type="other">Corbett R, Eveleigh R, Whitney J, Barai N, Bourgey M, Chuah E, et al. A distributed whole genome sequencing benchmark study. Front Genet. 2020;11:612515.</mixed-citation>
    </ref>
    <ref id="CR22">
      <label>22.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zook</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Catoe</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>McDaniel</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Extensive sequencing of seven human genomes to characterize benchmark reference materials</article-title>
        <source>Sci Data</source>
        <year>2016</year>
        <volume>3</volume>
        <issue>1</issue>
        <fpage>1</fpage>
        <lpage>26</lpage>
      </element-citation>
    </ref>
    <ref id="CR23">
      <label>23.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tommaso</surname>
            <given-names>PD</given-names>
          </name>
          <name>
            <surname>Chatzou</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Floden</surname>
            <given-names>EW</given-names>
          </name>
          <name>
            <surname>Barja</surname>
            <given-names>PP</given-names>
          </name>
          <name>
            <surname>Palumbo</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Notredame</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>Nextflow enables reproducible computational workflows</article-title>
        <source>Nat Biotechnol</source>
        <year>2017</year>
        <volume>35</volume>
        <issue>4</issue>
        <fpage>316</fpage>
        <lpage>319</lpage>
        <?supplied-pmid 28398311?>
        <pub-id pub-id-type="pmid">28398311</pub-id>
      </element-citation>
    </ref>
    <ref id="CR24">
      <label>24.</label>
      <mixed-citation publication-type="other">Mölder F, Jablonski KP, Letcher B, et al. Sustainable data analysis with Snakemake [version 2; peer review: 2 approved]. F1000Research. 2021;10:33.</mixed-citation>
    </ref>
    <ref id="CR25">
      <label>25.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Van der Auwera </surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>O’Connor</surname>
            <given-names>B</given-names>
          </name>
        </person-group>
        <source>Genomics in the cloud: Using Docker, GATK, and WDL in Terra. 1st ed. </source>
        <year>2020</year>
        <publisher-name>O’Reilly Media</publisher-name>
      </element-citation>
    </ref>
    <ref id="CR26">
      <label>26.</label>
      <mixed-citation publication-type="other">Illumina, Inc. DRAGMAP. 2019. [Accessed Summer 2022]. Available from: <ext-link ext-link-type="uri" xlink:href="https://github.com/Illumina/DRAGMAP">https://github.com/Illumina/DRAGMAP</ext-link>.
</mixed-citation>
    </ref>
    <ref id="CR27">
      <label>27.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Szolek</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Schubert</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Mohr</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Sturm</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kohlbacher</surname>
            <given-names>O</given-names>
          </name>
        </person-group>
        <article-title>OptiType: Precision HLA typing from next-generation sequencing data</article-title>
        <source>Bioinforma Oxf Engl</source>
        <year>2014</year>
        <volume>30</volume>
        <issue>23</issue>
        <fpage>3310</fpage>
        <lpage>3316</lpage>
      </element-citation>
    </ref>
    <ref id="CR28">
      <label>28.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Danecek</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Bonfield</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Twelve years of SAMtools and BCFtools</article-title>
        <source>Gigascience</source>
        <year>2021</year>
        <volume>10</volume>
        <issue>2</issue>
        <fpage>008</fpage>
      </element-citation>
    </ref>
    <ref id="CR29">
      <label>29.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Flickinger</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Gagliano </surname>
            <given-names>Taliun S</given-names>
          </name>
          <collab>InPSYght Psychiatric Genetics Consortium</collab>
          <name>
            <surname>Abecasis</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Scott</surname>
            <given-names>L</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Ancestry-agnostic estimation of DNA sample contamination from sequence reads</article-title>
        <source>Genomic Res</source>
        <year>2020</year>
        <volume>30</volume>
        <issue>2</issue>
        <fpage>185</fpage>
        <lpage>94</lpage>
      </element-citation>
    </ref>
    <ref id="CR30">
      <label>30.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Purcell</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Neale</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Todd-Brown</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Thomas</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Ferreira</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Bender</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>Plink: A tool set for whole-genome association and population-based linkage analyses</article-title>
        <source>Am J Hum Genet</source>
        <year>2007</year>
        <volume>81</volume>
        <issue>3</issue>
        <fpage>559</fpage>
        <lpage>575</lpage>
        <?supplied-pmid 17701901?>
        <pub-id pub-id-type="pmid">17701901</pub-id>
      </element-citation>
    </ref>
    <ref id="CR31">
      <label>31.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jin</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Schaffer</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Feolo</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Holmes</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Kattman</surname>
            <given-names>B</given-names>
          </name>
        </person-group>
        <article-title>GRAF-pop: A fast distance-based method to infer subject ancetry from multiple genotype datasets without principal components analysis</article-title>
        <source>G3 Bethesda Md.</source>
        <year>2019</year>
        <volume>9</volume>
        <issue>8</issue>
        <fpage>2447</fpage>
        <lpage>61</lpage>
        <?supplied-pmid 31151998?>
        <pub-id pub-id-type="pmid">31151998</pub-id>
      </element-citation>
    </ref>
    <ref id="CR32">
      <label>32.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jin</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Schaffer</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Sherry</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Feolo</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Quickly identifying identical and closely related subjects in large databases using genotype data</article-title>
        <source>PLoS ONE</source>
        <year>2017</year>
        <volume>12</volume>
        <issue>6</issue>
        <fpage>e0179106</fpage>
        <?supplied-pmid 28609482?>
        <pub-id pub-id-type="pmid">28609482</pub-id>
      </element-citation>
    </ref>
    <ref id="CR33">
      <label>33.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chang</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Chow</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Tellier</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Vattikuti</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Purcell</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Second-generation PLINK: Rising to the challenge of larger and richer datasets</article-title>
        <source>Gigascience</source>
        <year>2015</year>
        <volume>4</volume>
        <issue>7</issue>
        <fpage>13742</fpage>
        <lpage>13815</lpage>
      </element-citation>
    </ref>
    <ref id="CR34">
      <label>34.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <collab>R Core Team</collab>
        </person-group>
        <source>R: A language and environment for statistical computing</source>
        <year>2022</year>
      </element-citation>
    </ref>
    <ref id="CR35">
      <label>35.</label>
      <mixed-citation publication-type="other">Roslin N, Weili L, Paterson A, Strug L. Quality control analysis of the 1000 Genome Project Omni2,5 genotypes. bioRxiv. 2016. 10.1101/078600v1.
</mixed-citation>
    </ref>
    <ref id="CR36">
      <label>36.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <collab>The 1000 Genomes Project Consortium</collab>
        </person-group>
        <article-title>A global reference for human genetic variation</article-title>
        <source>Nature</source>
        <year>2015</year>
        <volume>526</volume>
        <fpage>68</fpage>
        <lpage>74</lpage>
        <pub-id pub-id-type="pmid">26432245</pub-id>
      </element-citation>
    </ref>
    <ref id="CR37">
      <label>37.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Meyer</surname>
            <given-names>HV</given-names>
          </name>
        </person-group>
        <source>meyer-lab-cshl/plinkQC: plinkQC 0.3.2</source>
        <year>2020</year>
      </element-citation>
    </ref>
    <ref id="CR38">
      <label>38.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tremblay</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Rousseau</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Zawati</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Auld</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Chasse</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Coderre</surname>
            <given-names>D</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The Biobanque quebecoise de la COVID-19 (BQC19)–a cohort to prospectively study the clinical and biological determinants of COVID-19 clinical trajectories</article-title>
        <source>PLOS ONE</source>
        <year>2021</year>
        <volume>16</volume>
        <issue>5</issue>
        <fpage>e0245031</fpage>
        <?supplied-pmid 34010280?>
        <pub-id pub-id-type="pmid">34010280</pub-id>
      </element-citation>
    </ref>
    <ref id="CR39">
      <label>39.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Dursi</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Bozoky</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>de Borja</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Lipski</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Brudno</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Federated network across Canada for multi-omic and health data discovery and analysis</article-title>
        <source>Cell Genomics</source>
        <year>2021</year>
        <volume>1</volume>
        <issue>2</issue>
        <fpage>100033</fpage>
        <?supplied-pmid 36778585?>
        <pub-id pub-id-type="pmid">36778585</pub-id>
      </element-citation>
    </ref>
    <ref id="CR40">
      <label>40.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fiume</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Cupak</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Keenan</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Rambla</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>de la Torre</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Dyke</surname>
            <given-names>S</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Federated discovery and sharing of genomic data using Beacons</article-title>
        <source>Nat Biotechnol</source>
        <year>2019</year>
        <volume>37</volume>
        <issue>3</issue>
        <fpage>220</fpage>
        <lpage>224</lpage>
        <?supplied-pmid 30833764?>
        <pub-id pub-id-type="pmid">30833764</pub-id>
      </element-citation>
    </ref>
    <ref id="CR41">
      <label>41.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lin</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Zeng</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>Proper analysis of secondary phenotype data in case-control association studies</article-title>
        <source>Genet Epidemiol</source>
        <year>2009</year>
        <volume>33</volume>
        <issue>3</issue>
        <fpage>256</fpage>
        <lpage>265</lpage>
        <?supplied-pmid 19051285?>
        <pub-id pub-id-type="pmid">19051285</pub-id>
      </element-citation>
    </ref>
    <ref id="CR42">
      <label>42.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ma</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Blackwell</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Boehnke</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Scott</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>Recommended joint and meta-analysis strategies for case-control association testing of single low-count variants</article-title>
        <source>Genet Epidemiol</source>
        <year>2013</year>
        <volume>37</volume>
        <issue>6</issue>
        <fpage>539</fpage>
        <lpage>550</lpage>
        <?supplied-pmid 23788246?>
        <pub-id pub-id-type="pmid">23788246</pub-id>
      </element-citation>
    </ref>
    <ref id="CR43">
      <label>43.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>DG</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Min</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>Relative efficiency of using summary versus individual data in random-effects meta-analysis</article-title>
        <source>Biometrics</source>
        <year>2020</year>
        <volume>76</volume>
        <issue>4</issue>
        <fpage>1319</fpage>
        <lpage>1329</lpage>
        <?supplied-pmid 32056197?>
        <pub-id pub-id-type="pmid">32056197</pub-id>
      </element-citation>
    </ref>
    <ref id="CR44">
      <label>44.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kraft</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Yen</surname>
            <given-names>YC</given-names>
          </name>
          <name>
            <surname>Stram</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Morrison</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Gauderman</surname>
            <given-names>W</given-names>
          </name>
        </person-group>
        <article-title>Exploiting gene-environment interactions to detect genetic associations</article-title>
        <source>Hum Hered</source>
        <year>2007</year>
        <volume>63</volume>
        <issue>2</issue>
        <fpage>111</fpage>
        <lpage>119</lpage>
        <?supplied-pmid 17283440?>
        <pub-id pub-id-type="pmid">17283440</pub-id>
      </element-citation>
    </ref>
    <ref id="CR45">
      <label>45.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Griffith</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Collider bias undermines our understanding of COVID-19 disease risk and severity</article-title>
        <source>Nat Commun</source>
        <year>2020</year>
        <volume>11</volume>
        <issue>1</issue>
        <fpage>1</fpage>
        <lpage>12</lpage>
        <pub-id pub-id-type="pmid">31911652</pub-id>
      </element-citation>
    </ref>
    <ref id="CR46">
      <label>46.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tao</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Zeng</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Franceschini</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>North</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Boerwinkle</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>DY</given-names>
          </name>
        </person-group>
        <article-title>Analysis of sequence data under multivariate trait-dependent sampling</article-title>
        <source>J Am Stat Assoc</source>
        <year>2015</year>
        <volume>110</volume>
        <issue>510</issue>
        <fpage>560</fpage>
        <lpage>572</lpage>
        <?supplied-pmid 26366025?>
        <pub-id pub-id-type="pmid">26366025</pub-id>
      </element-citation>
    </ref>
    <ref id="CR47">
      <label>47.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lawless</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Kalbfleisch</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Wild</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>Semiparametric methods for response-selective and missing data problems in regression</article-title>
        <source>Stat Methodol Ser B</source>
        <year>1999</year>
        <volume>61</volume>
        <issue>2</issue>
        <fpage>413</fpage>
        <lpage>438</lpage>
      </element-citation>
    </ref>
    <ref id="CR48">
      <label>48.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Huang</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>Efficient association mapping of quantitative trait loci with selective genotyping</article-title>
        <source>Am J Hum Genet</source>
        <year>2007</year>
        <volume>80</volume>
        <fpage>567</fpage>
        <lpage>576</lpage>
        <?supplied-pmid 17273979?>
        <pub-id pub-id-type="pmid">17273979</pub-id>
      </element-citation>
    </ref>
    <ref id="CR49">
      <label>49.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Monsees</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Tamimi</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Kraft</surname>
            <given-names>P</given-names>
          </name>
        </person-group>
        <article-title>Genome-wide association scans for secondary traits using case-control samples</article-title>
        <source>Genet Epidemiol</source>
        <year>2009</year>
        <volume>33</volume>
        <issue>8</issue>
        <fpage>717</fpage>
        <lpage>728</lpage>
        <?supplied-pmid 19365863?>
        <pub-id pub-id-type="pmid">19365863</pub-id>
      </element-citation>
    </ref>
    <ref id="CR50">
      <label>50.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tounkara</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Lefebvre</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Greenwood</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Oualkacha</surname>
            <given-names>K</given-names>
          </name>
        </person-group>
        <article-title>A flexible copula-based approach for the analysis of secondary phenotypes in ascertained samples</article-title>
        <source>Stat Med</source>
        <year>2020</year>
        <volume>39</volume>
        <issue>5</issue>
        <fpage>517</fpage>
        <lpage>543</lpage>
        <?supplied-pmid 31868965?>
        <pub-id pub-id-type="pmid">31868965</pub-id>
      </element-citation>
    </ref>
    <ref id="CR51">
      <label>51.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gail</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Wieand</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Piantadosi</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Biased estimates of treatment effect in randomized experiments with nonlinear regression and omitted covariates</article-title>
        <source>Biometrika</source>
        <year>1984</year>
        <volume>71</volume>
        <issue>3</issue>
        <fpage>431</fpage>
        <lpage>444</lpage>
      </element-citation>
    </ref>
    <ref id="CR52">
      <label>52.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pirinen</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Donnelly</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Spencer</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>Including known covariates can reduce power to detect genetic effects in case-control studies</article-title>
        <source>Nat Genet</source>
        <year>2012</year>
        <volume>44</volume>
        <issue>8</issue>
        <fpage>848</fpage>
        <lpage>851</lpage>
        <?supplied-pmid 22820511?>
        <pub-id pub-id-type="pmid">22820511</pub-id>
      </element-citation>
    </ref>
    <ref id="CR53">
      <label>53.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Herridge</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Cheung</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Tansey</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Matte-Martyn</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Diaz-Granados</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Al-Saidi</surname>
            <given-names>F</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>One-year outcomes in survivors of the acute respiratory distress syndrome</article-title>
        <source>N Engl J Med</source>
        <year>2003</year>
        <volume>348</volume>
        <issue>8</issue>
        <fpage>683</fpage>
        <lpage>693</lpage>
        <?supplied-pmid 12594312?>
        <pub-id pub-id-type="pmid">12594312</pub-id>
      </element-citation>
    </ref>
    <ref id="CR54">
      <label>54.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lederer</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Bell</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Branson</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Chalmers</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Marshall</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Maslove</surname>
            <given-names>D</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Control of confounding and reporting of results in causal inference studies. Guidance for authors from editors of respiratory, sleep, and critical care journals</article-title>
        <source>Ann Am Thorac Soc</source>
        <year>2019</year>
        <volume>16</volume>
        <issue>1</issue>
        <fpage>22</fpage>
        <lpage>8</lpage>
        <?supplied-pmid 30230362?>
        <pub-id pub-id-type="pmid">30230362</pub-id>
      </element-citation>
    </ref>
    <ref id="CR55">
      <label>55.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Aschard</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Vilhjalmsson</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Joshi</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Price</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Kraft</surname>
            <given-names>P</given-names>
          </name>
        </person-group>
        <article-title>Adjusting for heritable covariates can bias effect estimates in Genome-Wide Association Studies</article-title>
        <source>Am J Hum Genet</source>
        <year>2015</year>
        <volume>96</volume>
        <issue>2</issue>
        <fpage>329</fpage>
        <lpage>339</lpage>
        <?supplied-pmid 25640676?>
        <pub-id pub-id-type="pmid">25640676</pub-id>
      </element-citation>
    </ref>
    <ref id="CR56">
      <label>56.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Peckham</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>de Gruijter</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Raine</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Radzisweska</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Ciurtin</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Wedderburn</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission</article-title>
        <source>Nat Commun</source>
        <year>2020</year>
        <volume>11</volume>
        <issue>1</issue>
        <fpage>1</fpage>
        <lpage>10</lpage>
        <pub-id pub-id-type="pmid">31911652</pub-id>
      </element-citation>
    </ref>
    <ref id="CR57">
      <label>57.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Vahidy</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Pan</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Ahnstedt</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Munshi</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Choi</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Tiruneh</surname>
            <given-names>Y</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Sex differences in susceptibility, severity, and outcomes of coronavirus disease 2019: Cross-sectional analysis from a diverse US metropolitan area</article-title>
        <source>PLoS ONE</source>
        <year>2021</year>
        <volume>16</volume>
        <issue>1</issue>
        <fpage>e0245556</fpage>
        <?supplied-pmid 33439908?>
        <pub-id pub-id-type="pmid">33439908</pub-id>
      </element-citation>
    </ref>
    <ref id="CR58">
      <label>58.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pradhan</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Olasson</surname>
            <given-names>PE</given-names>
          </name>
        </person-group>
        <article-title>Sex differences in severity and mortality from COVID-19: Are males more vulnerable?</article-title>
        <source>Biol Sex Differ</source>
        <year>2020</year>
        <volume>11</volume>
        <fpage>53</fpage>
        <?supplied-pmid 32948238?>
        <pub-id pub-id-type="pmid">32948238</pub-id>
      </element-citation>
    </ref>
    <ref id="CR59">
      <label>59.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Song</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Biernacka</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Winham</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Testing and estimation of X-chromosome SNP effects: Impact of model assumptions</article-title>
        <source>Genet Epidemiol</source>
        <year>2021</year>
        <volume>45</volume>
        <issue>6</issue>
        <fpage>577</fpage>
        <lpage>592</lpage>
        <?supplied-pmid 34082482?>
        <pub-id pub-id-type="pmid">34082482</pub-id>
      </element-citation>
    </ref>
    <ref id="CR60">
      <label>60.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tukiainen</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Villani</surname>
            <given-names>AC</given-names>
          </name>
          <name>
            <surname>Yen</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Rivas</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Marshall</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Satija</surname>
            <given-names>R</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Landscape of X chromosome inactivation across human tissues</article-title>
        <source>Nature</source>
        <year>2017</year>
        <volume>550</volume>
        <issue>7675</issue>
        <fpage>244</fpage>
        <lpage>248</lpage>
        <?supplied-pmid 29022598?>
        <pub-id pub-id-type="pmid">29022598</pub-id>
      </element-citation>
    </ref>
    <ref id="CR61">
      <label>61.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>X</given-names>
          </name>
        </person-group>
        <article-title>Optimal tests for rare variant effects in sequencing association studies</article-title>
        <source>Biostatistics</source>
        <year>2012</year>
        <volume>13</volume>
        <issue>4</issue>
        <fpage>762</fpage>
        <lpage>775</lpage>
        <?supplied-pmid 22699862?>
        <pub-id pub-id-type="pmid">22699862</pub-id>
      </element-citation>
    </ref>
    <ref id="CR62">
      <label>62.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Talluri</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Shete</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Selection of X-chromosome inactivation model</article-title>
        <source>Cancer Inform</source>
        <year>2017</year>
        <volume>16</volume>
        <fpage>1</fpage>
        <lpage>8</lpage>
        <pub-id pub-id-type="pmid">28096648</pub-id>
      </element-citation>
    </ref>
    <ref id="CR63">
      <label>63.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Craiu</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>Bayesian model averaging for the X-chromosome inactivation dilemma in genetic association study</article-title>
        <source>Biostatistics</source>
        <year>2020</year>
        <volume>21</volume>
        <issue>2</issue>
        <fpage>319</fpage>
        <lpage>335</lpage>
        <?supplied-pmid 30247537?>
        <pub-id pub-id-type="pmid">30247537</pub-id>
      </element-citation>
    </ref>
    <ref id="CR64">
      <label>64.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Craiu</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Strug</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>The X factor: A robust and powerful approach to X-chromosome-inclusive whole-genome association studies</article-title>
        <source>Genet Epidemiol</source>
        <year>2021</year>
        <volume>45</volume>
        <issue>7</issue>
        <fpage>694</fpage>
        <lpage>709</lpage>
        <?supplied-pmid 34224641?>
        <pub-id pub-id-type="pmid">34224641</pub-id>
      </element-citation>
    </ref>
    <ref id="CR65">
      <label>65.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Derkach</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Lawless</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>Pooled association tests for rare genetic variants: A review and some new results</article-title>
        <source>Stat Sci</source>
        <year>2014</year>
        <volume>29</volume>
        <issue>2</issue>
        <fpage>302</fpage>
        <lpage>321</lpage>
      </element-citation>
    </ref>
    <ref id="CR66">
      <label>66.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Abecasis</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Boehnke</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>X</given-names>
          </name>
        </person-group>
        <article-title>Rare-variant association analysis: Study designs and statistical tests</article-title>
        <source>Am J Hum Genet</source>
        <year>2014</year>
        <volume>95</volume>
        <issue>1</issue>
        <fpage>5</fpage>
        <lpage>23</lpage>
        <?supplied-pmid 24995866?>
        <pub-id pub-id-type="pmid">24995866</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
